書籍詳細

子宮頸癌の概説

P.6 掲載の参考文献

• 1) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会(編):子宮頸癌取扱い規約, 改訂第2版. 1997;pp1-52, 金原出版, 東京

P.20 掲載の参考文献

• 1) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会(編):子宮頸癌取扱い規約, 改訂第2版. 1997;pp519, 金原出版, 東京

• 2) Creasman WT:Editorial. New gynecologic cancer staging. Gynecol Oncol 1995;58:157-158

• 3) 日本圧科婦人科学会, 日本病理学会, 日本医学放射線学会(編):子宮頸癌取扱い規約, 改訂第2版. 1997;pp53-73, 金原出版, 東京

• 4) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会(編):子宮頸癌取扱い規約, 改訂第2版. 1997;pp47-48, 金原出版, 東京

• 5) 三谷 靖, 山辺 徹:子宮頸癌の基礎的諸問題. 現代産科婦人科学大系8E, 子宮頸癌. 1970;pp3-32, 中山書店, 東京

• 6) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会(編):子宮頸癌取扱い規約. 1987;pp53 61, 金原出版, 東京

• 7) Scully RE, Bonfiglio TA, et al:Histological Typing of Female Genital Tract Tumours, 2nd ed. World Health Organization. 1994. Springer Verlag, Berlin

• 8) Sobin LE, Wittekind C(eds):TNM Classification of Malignant Tumours, 5th ed. International Union Against Cancer. 1997, Wiley-Liss, New York

P.34 掲載の参考文献

• 1) 厚生省大臣官房統計情報部(編):平成7年人口動態統計上巻. 1997, 厚生統計協会, 東京

• 2) 黒石哲生, 広瀬かおる, ほか:日本におけるがん死亡. がん・統計白書-罹患/死亡/予後-1999(富永祐民, 大島 明, ほか編). 1999;pp1-84, 篠原出版, 東京

• 3) Oshima A, Wakiko A, et al:Significance and usefulness of cancer registries. Int J Clin Oncol 1998;3:343-350

• 4) 黒石哲生, 西川陽子, ほか:世界各国のがん死亡の動向-33力国における部位別がんの年齢調整死亡率(1953-92). がん死亡. がん・統計白書-罹患/死亡/予後 1999(富永祐民, 大島 明, ほか編). 1999;pp187-264, 篠原出版, 東京

• 5) Parkin DM, Whelan SL, Ferley J(eds):Cancer Incidence in Five Continents, vol VII, IARC Sci Publ No 143. 1997;pp862-867, International Agency for Research on Cancer (IARC) and International Association of Cancer Registries(IACR), Lyon

• 6) Buckley JD, Harris RWC, et al:Case-control study of the husbands of women with dysplasia or carcinoma of the cervix uteri. Lancet 1981;ii:1010-1014

• 7) 富永祐民:頸癌-疫学. 図説臨床癌シリーズ No 12, 子宮頸癌・体癌(末舛恵一, 野田起一郎, 編). 1987;pp76-85, メジカルビュー社, 東京

• 8) Hirose K, Tajima K, et al:Subsite (cervix/endometrium):Specific risk and protective factors in uterus cancer. Jpn J Cancer Res 1996;87:1001-1009

• 9) Martin GE:Epidemiology of cancer of the cervix. II. Marital and coital factors in cervix cancer. Am J Public Health 1967;57:803-814

• 10) 森 満, 三宅浩次, 貞本晃一:北海道内市部における子宮癌標準化死亡比と離婚率の相関関係. 北海道の公衆衛生1985;11:50-53

P.55 掲載の参考文献

• 1) Fraumeni JF, Lloyd JW, et al:Cancer mortality among nuns:Role of marital status in etiology of neoplastic disease in woman. J Natl Cancer Inst 1969;42:455-468

• 2) Brinton LA:Epidemiology of cervical cancer-overview. The Epidemiology of Human Papillomavirus and Cervical Cancer (Munoz N, Bosch FX, et al, eds). IARC Scientific Publications, No 119. 1994;pp3-23. IARC, Lyon

• 3) Buckley JD, Harris RWC, et al:Case-control study of the husbands of women with dysplasia or carcinoma of the cervix uteri. Lancet 1981;ii:1010-1015

• 4) Kessler H:Venereal factors in human cervical cancers:Evidence from marital clusters. Cancer 1977;39:1912-1919

• 5) Kjaer SK, de Villiers EM, et al:Case-control study of risk factors for cervical neoplasia in Denmark I:Role of the "male factor" in women with one lifetime sexual partner. Int J Cancer 1991;48:39-44

• 6) Richart RM, Barron BA:A follow up study of patients with cervical dysplasia. Am J Obstet Gynecol 1969;105:386-393

• 7) Yoshikawa H, Nagata C, et al:Human papilloma, virus infection and other risk factors for cervical intraepithelial neoplasia in Japan. Br J Cancer 1999;80:621-624

• 8) Schiffman MH, Bauer HM, et al:Epidemiologic evidence showing that human papillomavirus infections causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-964

• 9) Becker TM, Wheeler CM, et al:Contraceptive and reproductive risks for cervical dysplasia in southwestern Hispanic and non-Hispanic women. Int J Epidemiol 1994;23:913-920

• 10) Chen YH Huang LH, Chen TM:Differential effects of progestins and estrogens on long control regions of human papillomavirus types 16 and 18. Biochem Biophys Res commun 1996;224:651-659

• 11) Kruger-Kjaer S, van den Brule AJ, et al:Different risk factors for high-grade and low grade intraepithelial lesionson the cervix among HPV positive and HPV negative young women. Int J Cancer 1998;76:613-619

• 12) Naib ZM, Nahmias AJ, et al:Genital herpetic infection association with cervical dysplasia. Cancer 1969;23:940-945

• 13) Nahmias AJ, Dowdle W:Antigenic and biological differences in herpesvirus hominis. Prog Med Virol 1968;10:110-159

• 14) Rawls WE, Tompkins WAF, Melnick JL:The association of herpesvirus type 2 and carcinoma of the uterine cervix. Am J Epidemiol 1969;89:547-554

• 15) 川名 尚, 橋戸 円:微量中和法による型別抗単純ヘルペスウイルス抗体測定法の評価. 臨床ウイルス1991;19:347-351

• 16) Lee FK, Colemati RM, et al:Detection of herpes simplex virus type 2-specific antibody with glycoprotein G, J Clin Microbiol 1985;22:641-644

• 17) Kawana T, Kawaguchi T, Sakamoto S:Clinical and virological studies on genital herpes. Lancet 1976;October 30, 1964

• 18) Hollinshead AC, Lee O, et al:Antibodies to herpesvirus nonvirion antigens in squamous carcinoma, Science 1973;182:7103-715

• 19) Aurelian L, Davis HJ, Julian CG:Herpes, virus-type 2 induced tumor-specific antigens in cervical carcinoma, Am J Epidemiol 1973;98:1-9

• 20) Kawana T, Cornisch JD, et al:Frequency of antibody to a virus-induced, tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls. Cancer Res 1976;36:810-820

• 21) Duff R, Rapp F:Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2. Nature New Biol 1971;233:48-50

• 22) Camacho A, Spear PG:Transformation of hamster embryo fibroblasts by specific fragment of the herpes simplex virus genome. Cell 1978;15:993-1002

• 23) Jariwalla RJ, Aurelian L, Ts'o POP:Tumorigenic transformation induced by specific fragment of herpes simplex virus type 2 DNA. Proc Natl Acad Sci USA 1980;77:880-884

• 24) Galloway DA, McDougall JK:The oncogenic potential of herpes simplex viruses:Evidence for a 'hit and run' mechanism. Nature 1983;302:21-24

• 25) Palmer AE, London WT, el al:A preliminary report on investigation of oncogenic potential of herpes simplex virus type 2 in Cebus monkey. Cancer Res 1976;36:807-809

• 26) Nahmias AJ, Naib ZM, et al:Prospective studies of the association of genital herpes simplex infections and cervicalanaplasia. Cancer Res 1973;33:1491-1497

• 27) Coleman DV, Morse AR, et al:Prognostic significance of herpes simplex virus antibody status in women with cervical intraepithelial neoplasia(CIN). Br J Obstet Gynaecol 1983;90:421-427

• 28) Vonka V, Kanka J, et al:Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus, II Herpes simplex type-2 antibody presence in sera taken at enrolment. Int J Cancer 1984;33:61-66

• 29) Lehtinen M, Hakama M, et al:Herpes simplex virus type 2 infection and cervical cancer:A prospective study of 12 years of follow-up in Finland. Cancer Causes Control 1992;3:333-338

• 30) zur Hausen H:Human genital cancer:Synergism between two virus infection or synergism between a virus infection and initiating events? Lancet 1982;ii:1370-1372
  pubmed

• 31) Hara Y, Kimoto T, et al:Effect of herpes simplex virus on the DNA of human papillomavirus 18. J Med Virol 1997;53:4-12

• 32) DiPaolo JA, Woodworth CD, et al:HSV-2-induced tumorigenicity in HPV-16 immortalized human genital keratinocytes. Virology 1990;177:777-779

• 33) Hildesheim A, Mann V, et al:Herpes simplex virus type 2:A possible interaction with human papilloma virus types 16/18 in the development of invasive cervical cancer. Int J Cancer 1991;49:335-340

• 34) De Villiers EM, Gissmann L, zur Hausen H:Molecular cloning of viral DNA from human genital warts. J Virol 1981;40:932-935

• 35) Durst M, Gissmann L, et al:A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983;80:3812-3815

• 36) Yoshikawa H, Matsukura T, et al:Occurrence of human papillomvirus type 16 and 18 DNA in cervical carcinomas from Japan:Age of patients and histological type of carinomas. Jpn J Cancer Res 1985;76:667-671

• 37) Ranst MV, Kaplan JB, Burk RD:Phylogenetic classification of human papillomavirus:Correlation with clinical manifestations. J Gen Virol 1992;73:2653-2660

• 38) Bosch FX, Manos MM, et al:Prevalence of human papillomavirus in cervical cancer:A worldwide perspective. J Natl Cancer Inst 1995;87:796-802

• 39) Yamada T, Manos M, et al:Human papillomavirus type 16 sequence variation in cervical cancer:A worldwide perspective. J Virol 1997;71:2463-2472

• 40) Hecht JL, Kadish AS, et al:Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int J Cancer 1995;160:369-376

• 41) Park DJ, Wilezynski SP, et al:p53 mutation in HPV-negative cervical carcilloma. Oncogene 1994;9:205-210

• 42) Lungu O, Sun XW, et al:Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA 1992;267:2493-2496

• 43) Lorincz AT, Reid R, et al:Human papillomavirus infection of the cervix:Relative risk assocciation of 15 common anogenital types. Obstet Gynecol 1992;79:328-337

• 44) Matsukura T, Sugase M:Identification of genital human papillomaviruses in cervical biopsypecimens:Segregation of specific virus types in specific clinicopathologic lesions. Int J Cancer 1995;61:13-22

• 45) Yoshikawa H, Kawana T, et al:Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn Cancer Res 1991;82:524-531

• 46) Melkert PWJ, Hopman E, et al:Prevalence of HPV in cytomorphological normal cervical smears, as determined by the polymerase chain reaction, is age dependent. Int J Cancer 1993;53:919-923

• 47) Koutsky LA, Holmes KK, et al:A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillolnavirus infection. N Engl J Med 1992;327:1272-1278
  pubmed

• 48) Remmink AJ, Walboomers JMM, et al:The presence of persistent high-risk HPV genotypes in dysplastic cervical lesionsis associated with progressive disease:Natural history up 1036 months. Int J Cancer 1995;61:306-330

• 49) Ho GYF, Burk RD, et al:Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-1371

• 50) Ho GYF, Bierman R, et al:Natural history of cervicovaginal papillomavirus infection in young women. N Engl Med 1998;338:423-428

• 51) Schachter J, Hill EC, et al:Chlamydia trachomatis and cervical neoplasia. JAMA 1982;248:2134-2138

• 52) Lowy DR, Schiller JT:Papillomavirus and cervical cancer:Pathogenesis and vaccine development. Monogr Natl Cancer Inst 1998;23:27-30

• 53) Mansur CP, Androphy AJ:Cellular transformation by papillomavirus oncoprotein. Biochem Biophys Acta 1993;1155:323-34

• 54) 清野 透:発がんにおけるヒトパピローマウイルス遺伝子の役割. ウイルス1998;48:125-135

• 55) Xi LF, Koutsky LA, et al:Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepi thelial neoplasia. J Natl Cancer Inst 1997;89:796-802

• 56) Nakagawa M, Stites D, et al:Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16:Relationship to cervical intraepithelial neoplasia. J Infect Dis 1997;175:927-931

• 57) Matsumoto K, Yoshikawa H, et al:Balance of IgG subclasses toward human papillomavirus type 16 (HPVI6) L1-capsids is a possible predictor for the regression of HPV16-positive cervical intraepithelial neoplasia. Biochem Biophys Res Commun 1999;258:128-131

• 58) Matsumoto K, Yoshikawa H, et al:Antibodies to human papillomavirus 16, 18, 58 and 6b major capsid proteins among Japanese females. Jpn J Cancer 1997;88:369-375

• 59) Nonnenmacher B, Kjaer SK, et al:Seroreactivity to HPV 16 virus-like particles as a marker for cervical cancer risk in high risk populations. Int J Cancer 1996;68:704-709

• 60) Kawana K, Yoshikawa H, et al:In vitro construction of pseudovirions of human papillomavirus type 16:Incorporation of plasmid DNA into reassembled L1/L2 capsids. J Virol 1998;72:10298-10300

• 61) Onda T, Kanda T, et al:Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA. Int J Cancer 1993;54:624-628

• 62) Nakagawa S, Yoshikawa H, et al:Type of human papillomavirus is related to clinical features of cervical carcinoma. Cancer 1996;78:1935-1941

• 63) Alejo M, Macedo L et al:Adenocarcinoma in situ of the uterine cervix:Clinicopathological study of nine cases with detection of human papillomavirus DNA by in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 1993;12:219-223

• 64) Yokota J, Tsukada Y, et al:Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Rea 1989;49:3598-3601

• 65) Hampton GM, Penny LA, Baergen RN:Loss of heterozygosity in cervical carcinoma:Sub-chromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci USA 1994;91:6953-6957

• 66) Pinion SB, Kennedy JH, et al:Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of cervix. Lancet 1991;337:819-820

• 67) Hayashi Y, Hachisuga T, et al:Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement. Gynecol Oncol 1991;40:147-151

• 68) Nakagawa S, Yoshikawa H, et al:A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma or the uterine cervix. Br J Cancer 1999;79:589-594
  pubmed

• 69) Batieha AW, Armenian HK, et al:Serum micronutrients and the subsequent risk of cervical cancer in a population based nested case-control study. Cancer Epidemiol Biomarkers Prev 1993;2:335-339

• 70) Nagata C, Shimizu H, et al:Serum carotenoids and vitamins and risk of cervical dysplasia from a case-control study in Japan 1999;81:1234-1237

• 71) Wank R, Thomssen C:High risk of squamous cell carcinoma of the cervix for women with HLA DQw3. Nature 1991;352:723-7

• 72) Vandenvelde C, De Foor M, Beers DV:HLA-DQB1*03 and cervical intraepithelial neoplasia grades 1-111. Lancet 1993;341:442-443

P.71 掲載の参考文献

• 1) Williams J:Cancer of the uterus. Harveian Lectures for 1886. 1886, HK Lewis, London

• 2) Cullen TS:Cancer of the Uterus. 1900, Appleton and Company, New York

• 3) Broders AC:Carcinoma in situ contrasted with benign penetrating epithelium. JAMA 1932;99:1670-1674

• 4) Pemberton FA, Smith GV:The early diagnosis and prevention of carcinoma of the cervix:A clinical pathologic study of borderline cases treated at the Free Hospital for women. Am J Obstet Gynecol 1929;17:165

• 5) Smith GV, Pemberton FA:The picture of very early carcinoma of the uterine cervix. Surg Gynecol Obstet 1934;59:1-8

• 6) Koss LG, Stewart FW, et al:Some histological aspects of behavior of epidermoid carcinoma in situ and related lesions of the uterine cervix. Cancer 1963;16:1160-1211

• 7) Kolstad P, Klem V:Long-term follow-up of 1121 cases of carcinoma in situ. Obstet Gynecol 1979;48:125-133

• 8) Reagan JW, Hamonic MJ:The cellular pathology in carcinoma in situ:A correlation. Cancer 1956;9:385
  pubmed

• 9) Weid GL:Proceedings of the First International Congress on Exfoliative Cytology. 1961, JB Lippincott, Philadelphia

• 10) Scully RE, Bonfiglio TA, et al:Histologic typing of female genital tract tumors, 2nd ed. 1994;pp40-41. Springer-Verlag, New York

• 11) Siegler EE:Microdiagnosis of carcinoma in situ of the uterine cervix:A comparative study of pathologists diagnoses. Cancer 1956;9:463
  pubmed

• 12) Kirkland JA:A typical epithelial changes in the uterine cervix. J Clin Pathol 1963;16:150-154

• 13) Crocker J, Fox H, Langley FA:Consistency in the histological diagnosis of epithelial abnormalitiesof the cervix uteri. J Clin Pathol 1968;21:67-70

• 14) Richart RM:A theory of cervical carcinogenesis. Obstet Gynecol Surv 1969;24:874-879

• 15) Fu YS, Reagan J, Richart RM:Precursors of cervical cancer. Cancer Surv 1983;2:359-382

• 16) Richart RM:Natural history of cervical intraepithelial neoplasia. Clin Obstet Gynecol 1968;10:748-784

• 17) Richart RM:Cervical intraepithelial neoplasia:A review. Pathology Annual (Sommers SC, ed). 1973;pp301-328. Appleton Century Crofrs, East Norwalk

• 18) Wright TC, Richart RM:Role of human papillomavirus in the pathogenesis of genital tract warts and cancer. Gynecol Oncol 1990;37:151-164

• 19) zur Hausen H:Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991;184:9-13

• 20) Fu YS, Braun L et al:Histologic nuclear DNA, and human papillomavirus studies of cervicalondylomas. Cancer 1983;52:1705-1711

• 21) Willet GD, Kurman RJ, et al:Correlation of the histological appearance or intraepithelial neoplasia of the cervix with human papillomavirus types. Int Gynecol Pathol 1989;8:18-25
  pubmed

• 22) Bergeron C, Barrasso R, et al:Human papillomaviruses associated with cervical intraepithelialeoplasia. Great diversity and distinct distribution in low and high-grade lesions. Am J Surg Pathol 1992;16:641-649

• 23) Lungu O, Sun XW, et al:Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA 1992;267:2493-2496

• 24) Richart RM:A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol 1990;75:131-133

• 25) National Cancer Institute Workshop:The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. JAMA 1989;262:931-934

• 26) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会(編):子宮頸癌取扱い規約, 改訂第2版. 1997;pp55-56, 金原出版, 東京

• 27) 野田起一郎:上皮内癌および高度異形成の臨床. 第29回日本産科婦人科学会学術講演会教育講記録. 1997

• 28) Noda K, Yajima A, et al:Histopathologic criterion of dysplasia of the uterine cervix and its biological nature. Acta Cytol 1976;20:224-228

• 29) 大塚誠一:子宮頸部異形成の臨床病理学的研究. 日本産科婦人科学会雑誌1971;23:163-172

• 30) 栗原操寿:子宮頸部の前癌病変に関する研究. 日本産科婦人科学会雑誌1972;24:663-672

• 31) Richart RM, Barron BA:A flow-up study of patients with cervical dysplasia. Am J Obstet Gynecol 1969;105:386-393

• 32) Richart RM:Influence of diagnostic and therapeutic procedures on the distribution of cervical intraepithelial neoplasia. Cancer 1966;19:1635-1638

• 33) Nasiell K, Nasiell M, Vaclavinkova V:Behavior of moderate cervical dysplasia during long-term low-up. Obstet Gynecol 1983;61:609-614

• 34) Nasiell K, Roger V, Nasiell M:Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986;67:655-669

• 35) Meisels A, Morin C, Casas-Cordero M:Lesions of the uterine cervix associated vith papillomaviruses and their clinical consequences. Adv Clin Cytol 1984;2:1-31

• 36) Robertson JH, Woodend BE, et al:Risk of cervical cancer associated with mild dyskaryosis. Br Med J 1988;1297:18-21

• 37) Murthy NS, Sehgal A, et al:Risk factors related to biological behaviour of precancerous lesions of the uterine cervix. Br J Cancer 1990;61:732-736

• 38) Greenberg M, Reid R, et al:A prospective natural history study of minor grade cervical lesions:preliminary report. Abstracts, Fifth Human Papillomavirus Meeting. 1992, Chicago

• 39) Montz FJ, Mok BJ, et al:Natural history of the minimally abnormal Papallicolaou smear, Obstet Gynecol 1992;80:385-3

• 40) Iwasaka T, Matsuo N, et al:Prospective follow-up of Japanese women with cervical intraepithelia neoplasia and various human papillomavirus types. Int J Gynecol Obstet 1998;62:269-277

• 41) McIndoe WA, McLean MR, et al:The invasive potential of carcinoma in sutu of the cervix. Obstet Gynecol 1984;64:451-458

• 42) Kottmeier HL:Evolution et traitment des epitheliomas. Rev Fran Gynecol d'Obstet 1961;56:821-826

• 43) Spriggs AI Boddington MM:Progression and regression of cervical lesions:Review of smears from women followed without initial biopsy or treatment. J Clin Pathol 1980;33:517-525
  pubmed

• 44) Stern E, Neely PM:Carcinoma and dysplasia of the cervix:A comparison of rates for new and returning populations. Acta Gynecol 1963;7:356-361

• 45) Rubio CA, Lagerlof B:Studies on the histogenesis of experimentally induced cervical carcinoma. Acta Pathol Microbiol Scand 1974;82:153-160

• 46) Richart RM:Colpomicroscopic studies of the distribution of dysplasia and carcinoma in situ on the exposed portion of the human uterine cervix. Cancer 1965;18:950-954

• 47) Spriggs AI, Bowey CE, Cowdell RH:Chromosomcs of precancerous lesions of the cervix uteri. Cancer 1971;27:1239-1259

• 48) Burghardt E:Early Histological Diagnosis of Cervical Cancer. 1973, Georg Thieme Verlag, Stuttgart

• 49) Koss LG:Diagnostic Cytology and Its Histopathologic Basis. 1992, JB Lippincott, New York

• 50) Koutsky LA, Holmes KK, et al:A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillonlavirus infection. N Engl J Med 1992;327:1272-1278
  pubmed

• 51) Kiviat NB, Critchlow CW, Kurman RJ:Reassessment of the morphological continuum of cervical intraepithelia lesions:Does it reflect different stages in the progression to cervical carcinoma? The Epidemiology of Cervical Cancer and Human Papillomavirus (Munoz N, Bosch F et al, eds). 1992;pp59-66. IARC Lyons

• 52) Kataja V, Syrjanen K, et al:Prospective follow-up of genital HPV infections:Survival analysis of the HPV typing data. Eur J Epidemiol 1990;6:9-14
  pubmed

• 53) Moscicki AB, Palefsky J, et al:Variability of human papillomavirus DNA testing in a longitudinalcohort of young women. Obstet Gynecol 1993;82:578-585

• 54) Hellberg D, Nilson S, et al:Behavior of cervical intraepithelial neoplasia(CIN) associated witharious human papillomavirus (HPV) types. Arch Gynecol Obstet 1993;252:119-128

• 55) Iwasaka T, Yokoyama M, et al:In situ hybridization analysis of human papillomavirus DNA in cervical intraepithelial neoplasia:Prospective follow-up study. The cervix & lfgt 1994;12:55-58

• 56) Iwasaka T, Matsuo N, et al:Non-detection of human papillomavirus DNA incervical dysplasia and disease progression. Lancet 1996;348:333-334

• 57) Stewart FW:Factors influencing curability of cancer. Conference Proceedings of the Thirdational Cancer Conference. 1957;pp6273, JB Lippincott. Philadelphia

• 58) Helper TK, Dockerty MB, Randall LM:Primary adenocarcinoma of the cervix. Am J Obstet Gynecol 1952;63:800-808

• 59) Friedell GH, McKay DG:Adenocarcinoma in situ of endocervix. Cancer 1953;6:887-897

• 60) Bousfield L, Pacey F, et al:Expanded cytologic criteria for the diagnosis of adenocarcinoma in situ of the cervix and related lesions. Acta Cytol 1980;24:283-296

• 61) Gloor E, Hurlimann J:Cervical intraepithelial glandular neoplasia (adenocarcinoma in situ and landular dysplasia):A correlative study of 23 cases with histologic grading, histochemical analysis of mucins and immunohistochemical determination of the affinity for four lectins. Cancer 1986;58:1272-1280

• 62) Friedell GH, Tucker TC, et al:Incidence of dysplasia and carcinoma of the uterine cervix in Allppalachian population. J Natl Cancer Inst 1992;84:1030-1032

• 63) Brown LJR, Wells M:Cervical glandular atypia associated with squamous intraepithelial neoplasia:A premalignant lesion? J Clin Pathol 1986;39:22-28

• 64) Luesley DM, Jordan JA, et al:A retrospective review of adenocarcinoma in situ and glandular atypia of the uterine cervix. Br J Obstet Gynaecol 1987;94:699-703

• 65) Bodington MM, Spriggs AI, Cowdell RH:Adenocarcinoma of the uterine cervix:Cytological evidence of a long preclinical evolution. Br J Obstet Gynecol 1976;183:900-903

• 66) Boon ME, Baak JPA, et al:Adenocarcinoma in situ of the cervix:An underdiagnosed lesion. Cancer 1981;48:768-773

• 67) Kashimura M, Shinohara M, et al:An adenocarcinoma in stu of the uterine cervix that developed into invasive adenocar cinoma after 5 year. Gynecol Oncol 1990;36:128-133

• 68) Weisbrot IM, Stabinsky C, Davis M:Adenocarcinoma in situ of the uterine cerivix. Cancer 1972;29:1179-1187

• 69) Christpherson WM, Nealon N, Gray LA:Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri. Cancer 1979;44:975-983

• 70) Tobon H, Dave H:Adenocarcinoma in situ of the cervix. Int J Gynecol Pathol 1988;7:139-151

• 71) Anderson ES, Arffmann E:Adenocarcinoma in situ of the uterine cervix:A clinico-pathologic study of 36 cases. Gynecol Oncol 1989;35:1-7

• 72) Cullimore JE, Luesley DM, et al:A prospective study of conization of the cervix in the managemenl of cervical intrae pithelial glandular neoplasia(CIGN):A preliminary report Br J Obstet Gynecol 1992;88:314-318

• 73) Tase T, Okagaki T, et al:Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix and coexisting cervical squamous intraepithelial neoplasia. Int J Gynecol Pathol 1989;8:8-17
  pubmed

• 74) Famsworth A, Laverty C, Stoler MH:Human papillomavirus messenger RNA expression indenocarcinoma in situ of the uterine cervix. Int J Gynecol Pathol 1989;8:321-330

• 75) Griffin NR, Dockey D, et al:Demonstration of low frequency or human papillomavirus DNA in cervical adenocarcinoma and adenocarcinoma in situ by the polymerase chain reaction and in situ hybridization. Int J Gynecol Pathol 1991;10:36-43
  pubmed

• 76) Tase T, Okagaki T, et al:Human papillomavirus DNA in glandular dysplasia and microglandular hyperplasia:Presumed precursors of adenocarcinoma of the uterine cervix. Obstet Gynecol 1989;173:1005-1008

• 77) Samaratunga H Cox N, Wright RG:Human papinomavirus DNA in glandular lesions of the uterine cervix. J Clin Pathol 1993;46:718-721

• 78) Higgins GD, Phllips GE, et al:High prevalence of human papillomavirus transcripts in all grades of cervical intraepithelial glandular neoplasia. Cancer 1992;70:136-146

子宮頸癌の臨床

P.90 掲載の参考文献

• 1) 杉山裕子, 陳 瑞東, ほか:無症状子宮癌. 臨床成人病1997;27:310-314

• 2) 陳 瑞東, 片瀬功芳, 荷見勝彦:婦人科癌の悪液質とその治療. Biotheraohy 1994;8:51-58

• 3) Hasumi K, Sakamoto A, et al:Microinvasive carcinoma of the uterine cervix. Cancer 1980;45:928-931

• 4) Creasman WT, Zaino RJ, et al:Early invasive carcinoma of the cervix (3 to 5mm):Risk factors and prognosis. Am J Obstet Gynecol 1998;178:62-65

• 5) 松隈敬太, 三宅正晃, ほか:子宮頸癌の肺転移に対する手術療法の検討. 日本産科婦人科学会雑誌1989;41:1911-1915

• 6) Seki M, Nakagawa K, et al:Surgical treatment of metastases from uterine cervical cancer. J Thorac Cardiovasc Surg 1992;104:876-881

• 7) 松山敏剛, 塚本直樹, ほか:子宮頸癌の骨転移の検討. 産科と婦人科1987;54:1500-1504

• 8) 信永敏克, 山崎正人, ほか:子宮頸癌の骨転移症例の臨床病理学的検討. 日本癌治療学会誌 1988;23:1039-1045

• 9) 田内美紀, 須井 修, ほか:子宮頸癌の骨転移例の検討. 日本放射線腫瘍学会誌1990;2:111-117

• 10) 長井 裕, 東 政弘, ほか:子宮頸癌骨転移の臨床. 産婦人科の実際1997;46:1419-1424

• 11) Blythe JG, Ptacek JJ, et al:Bony metastases from carcinoma of cervix. Cancer 1975;36:475-484

• 12) 園田隆彦:子宮頸癌の遠隔転移. 産婦人科の実際1982;31:297-306

• 13) 岡村信介, 岡本吉明, ほか:骨シンチグラフィーを用いた子宮頸癌の骨転移に関する研究. 日本産科婦人科学会雑誌1985;37:603-610

• 14) 鈴木 瞭, 小澤 満:子宮頸癌I期に関する臨床的検討. IR YOU(医療)1998;52:410-414

• 15) 蔵本博行, 角田新平, ほか:子宮頸癌I期の新FIGO分類と旧日産婦分類との比較. 産婦人科の世界1998;50:523-531

• 16) 竹島信宏, 矢納研二, ほか:子宮頸癌Ia期(新規約)の臨床的取扱いについて-新FIGO Ia期子宮頸部扁上皮癌の取扱い. 産科と婦人科1998;65:1160-1165

• 17) 塩田 充, 小川誠司, ほか:子宮頸癌Ia期(新規約/新進行期分類)の臨床的取扱いについて. 産科と婦人科1998;65:1141-1145

• 18) 沼 文隆, 末広 寛, ほか:子宮頸癌Ia期(新規約)の臨床的取扱いについて-子宮頸癌Ia期のFIGO新分類(Ia1, Ia2)について. 産科と婦人科1998;65:1155-1159

• 19) 加藤久盛, 土居大祐, ほか:子宮頸癌Ia期(新規約)の臨床的取扱いについて-新FIGO分類による子宮頸癌Ia1, Ia2期の臨床的取扱いについての検討. 産科と婦人科1998;65:1147-1152

• 20) 工藤隆一, 寒河江悟:子宮頸癌の新取扱い規約(改訂第2版)-新取扱いについて. 産科と婦人科1998;65:1117-1124

• 21) Boyce JG, Fruchter RG, et al:Vascular invasion in stage 1 carcinoma of the cervix. Cancer 1984;53:1175-1180

• 22) Burghardt E, Pickel H, et al:Prognostic factors and operative treatment of stage IB to IIB cervical cancer. Am J Obstet Gynecol 1987;156:988-996

• 23) 横山 隆, 藤岡 徹, ほか:子宮頸癌の腫瘍径と治療成績. 産科と婦人科1997;64:1004-1008

• 24) Lambin PL, Kramer A, et al:Tumor size in cancer of the cervix. Acta Oncol 1998;37:729-734

• 25) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会(編):子宮頸癌取扱い規約, 改訂第2版. 1997, 金原出版, 東京

• 26) Sykes AJ, Shanks JH, Davidson SE:Small cell carcinoma of the uterine cervix:A clinicopathological review. Int J Oncol 1999;14:381-386

• 27) 横須賀薫, 荷見勝彦:子宮頸部腺癌の臨床病理学的検討. 日本癌治療学会誌1994;29:712-719

• 28) 横須賀薫, 荷見勝彦:内頸部型子宮頸部腺癌における予後因子の検討. 日本産科婦人科学会雑誌1994;46:889-895

• 29) Yamakawa Y, Forslund O, et al:Human papillomavirus DNA in adenocarcinoma and adeno-squamous carcinoma of the uterine cervix detected by polymerase chain reactlon. Gynecol Oncol 1994;53:190-195

• 30) Teshima H, Katase K, et al:Human papillomavirus type 18 DNA sequences in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Arch Gynecol Obstet 1997;259:169-177

• 31) 野田起一郎:子宮頸部腺癌の病理と臨床. 日本産科婦人科学会熊本地方部会雑誌1992;36:27-33

• 32) 宇津木久仁子, 清水敬生, ほか:子宮頸部腺癌完全手術後の再発危険因子と再発形式の検討. 日本産科婦人科学会雑誌1997;49:249-255

• 33) 岡本欣晃, 広田佐栄子, ほか:子宮頸部腺癌の放射線治療成績. 日本医学放射線学会雑誌 1997;57:936-941

• 34) Wentz WB, Reagan JW:Survival in cervical cancer with respect to cell type. Cancer 1958;12:384-388

• 35) Wentz WB:Histologic grade and survival in cervical cancer. Obstet Gynecol 1961;18:412-416

• 36) Wentz WB, Lewis GC:Correlation of histologic morphology and survival in cervical cancer following radiation therapy. Obstet Gynecol 1965;26:228-232

• 37) 今井 環:人体癌腫発育状況の形態学的考察. 福岡医学雑誌1954;2月:45-102

• 38) 児玉省二, 本間 滋, ほか:子宮頸部扁平上皮癌の予後因子に及ぼす年齢の影響についての検討. 日本癌治療学会誌1990;25:43-50

• 39) 児玉省二, 本間 滋, ほか:子宮頸癌のリンパ節転移について. 産科と婦人科1989;56:1835-1844

• 40) 杉森 甫, 塚本直樹, ほか:子宮頸癌の組織分類と予後との関係についての検討. 産科と婦人科1980;47:1333-1339

• 41) 高橋康一, 松原 雄, ほか:子宮頸癌の拡がり診断はどこまで可能か. 産科と婦人科1991;58:1474-1486

• 42) 高橋康一, 吉岡増夫, 中村幸雄:頸癌浸潤度(側方, 膀胱直腸浸潤). 臨床婦人科産科1995;49:34-41

• 43) 塚本直樹:子宮頸癌のリンパ節転移. 医学のあゆみ1991;156:244-246

• 44) 櫻木範明, 佐藤 力, ほか:子宮頸癌における旁大動脈リンパ節転移について. 日本産科婦人科学会雑誌1990;42:60-66

• 45) 水谷勝美, 村上 章, ほか:旁大動脈リンパ節郭清による子宮頸癌の後腹膜リンパ節転移様式と予後. 産婦人科の世界1997;49:47347

• 46) 櫻木範明, 晴山仁志, ほか:若年者における機能温存・機能代償. 産科と婦人科1998;65:713-720

• 47) 岩坂 剛, 安永牧生, 杉森 甫:高齢・合併症を考慮した低侵襲治療. 産科と婦人科1998;65:771-778

• 48) 三谷 靖, 山辺 徹:子宮頸癌の臨床-症状, 経過, 転帰. 現代産科婦人科学大系8E, 子宮頸癌. 1970;pp33-47, 中山書店, 東京

• 49) Graham RM, Graham JB:Cytological prognosis in cancer of the uterine cervix treated radiologically. Cancer 1955;8:59-65

• 50) 増淵一正, 天神美夫, ほか:リンパ節転移のない子宮頸癌手術例に後照射は必要か. 癌の臨床 1966;12:444-448

• 51) 竹島信弘, 荷見勝彦:骨盤内リンパ節転移と血中SCC抗原. 産婦人科の世界1998;50:479-484

• 52) 平林光司, 奥田博之:子宮頸癌における術後外照射法の研究. 日本産科婦人科学会雑誌1971;23:847-854

• 53) 荒居竜雄, 森田新六, ほか:子宮頸癌術後放射線治療の適応と評価. 産科と婦人科1983;50:1347-1355

• 54) Morris M, Eifel P, et al:Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-1143

• 55) 清水敬生:進行子宮頸癌に対する化学療法. 癌と化学療法1995;22:1152-1162

• 56) Shimizu Y, Akiyama F, et al:Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma. J Clin Oncol 1998;16:1869-1878

• 57) 杉森 甫, 塚本直樹, ほか:子宮頸癌の再発に関する検討. 産科と婦人科1980;47:1121-1126

• 58) 鶴地伸宏, 塚本直樹:再発子宮頸癌の治療. 産婦人科治療. 1994;69:361-365

• 59) 野口 浩:子宮頸癌再発の早期診断と治療. 産科と婦人科1986;53:1356-1364

• 60) 吉野内光夫, 中村圭一郎, ほか:子宮頸癌術後再発の予知. 産婦人科治療1998;77:436-440

• 61) Sommers GM, Grigsby PW, et al:Outcome of recurrent cervical carcinoma following definitive irradiation. Gynecol Oncol 1989;35:150-155

• 62) 加藤逸夫:四肢リンパ浮腫の治療. 日本医事新報1988;3325:9-16

P.102 掲載の参考文献

• 1) 栗原操寿:子宮頸部の前癌病変に関する研究-とくに良性悪性をめぐる境界病変について. 日本産科婦人科学会雑誌1972;24:663-672

• 2) 蔵本博行, 大野英治, ほか:dysplasia, CIS およびIa期癌の細胞所見による鑑別. 産科と婦人科1984;51:47-54

• 3) 牛島研作, 木村憲三, 野田起一郎:dysplasia, CIS およびIa期癌の細胞所見による鑑別. 産科と婦人科1984;51:3746

• 4) 角田新平, 上坊敏子, 蔵本博行:子宮頸部早期Ib期癌の細胞学的検討-Ia期癌との鑑別を中心に. 日本臨床細胞学会雑誌1993;32:14-20

• 5) 日本産婦人科学会, 日本病理学会, 日本医学放射線学会(編):子宮頸癌取扱い規約, 改訂第2版. 1997, 金原出版, 東京

• 6) 蔵本博行, 森沢孝行, ほか:子宮頸部の腺扁平上皮内癌. 日本臨床細胞学会雑誌1978;17:70-77

• 7) 芳賀厚子, 平井康夫, ほか:子宮頸部悪性腺腫 (adenoma malignum)の臨床細胞学的検討. 日本臨床細胞学会雑誌1995;34:1082-1088

P.145 掲載の参考文献

• 1) 辻井清重:コルポスコピーによる子宮頸癌早期診断に関する研究, とくにToluidine blue 生体染色法について. 産婦人科の進歩1972;24:27-41

• 2) 植木 実, 平井 博, ほか:コルポスコピーにおける子宮腟部血管像に関する研究, とくにアルカリフォスファターゼ組織染色所見および可視深度について. 産婦人科の進歩1973;25:687-690

• 3) 平井 博, 植木 実, ほか:コルポスコープ所見の質的ならびに量的解釈からみた異形成, 上皮内癌, 初期浸潤癌の鑑別. 産婦人科の進歩1974;26:279-284

• 4) 菊田正文:コルポスコピーにおける子宮腟部血管像の意義に関する研究. 日本産科婦人科学会雑誌1976;28:57-64

• 5) 浜田紘一郎:Colposcopyによる子宮頸部微小浸潤癌の診断学的研究. 日本産科婦人科学会雑誌 1977;29:371-380

• 6) Sugimoto O:Diagnostic and Therapeutic Hysteroscopy. 1978, Igaku-Shoin Medical Publishers Inc. Tokyo, New York

• 7) 渡辺克一, 飯藤容弘, ほか:子宮頸部癌術後の腟断端のコルポスコピー所見-とくに再発初期所見について. 産婦人科の進歩1980;32:563-566

• 8) Ueki M:Cervical Adenocarcinoma:A Colposcopic Atlas. 1984, Ishiyaku Euro America Inc, St Louis, Tokyo

• 9) 佐野 隆, 植木 実, 杉本 修:サービコスコピーによる子宮頸管内病変の観察とその診断的意義. 日本婦人科病理・コルポスコピー学会誌1986;4:131-137

• 10) Ueki M, Sano T:Cervical Carcinoma-A Cervicoscopic Atlas. 1987, Ishiyaku Euro America Inc, St Louis

• 11) Ueki M, Green GH:Cervical carcinoma in situ after incomplete conisation. Asia-Oceania J Obstet Gynaecol 1988;14:147-153

• 12) Ueki M, Kitsuki K, et al:Clinical evalution of contact Nd-YAG laser conization for cervical intraepithelial neoplasia of the uterus. Acta Obstet Gynecol Scand 1992;71:465-470

• 13) Ueki M, Okamoto Y, et al:Conservative therapy for microinvasive carcinoma of the uterine cervix. Gynecol Oncol 1994;53:109-113

• 14) Ueki M, Goto M, et al:Conservative therapy for early cancer of the uterine cervix during pregnancy. Bulletin of the Osaka Medical College 1994;40:55-58

• 15) Ueki M, Ueda M:Colposcopic appearance and the possibility of colposcopic diagnosis in early cervical adenocarcinoma. The Cervix and the Lower Female Genital Tract 1994;12:11-15

• 16) Ueki M, Ueda M, et al:Clinicopathological features of well-differentiated cervical adenocarcinoma with abundant mucus secretion. J Med 1995;26:17-30

• 17) Ueki M, Ueda M, et ai:Cervical cytology and conservative management of cervical neoplasia during Pregnancy. Int J Gynecol Pathol 1995;14:63-69

• 18) Ueki M:Colposcopy in Adenocarcinoma of the cervix. Cervical Cancer and Preinvasive Neoplasia. 1996;pp127-133, Lippincott-Raven, Philadelphia

• 19) 植木 實, 岡本吉明, ほか:子宮頸部初期癌に対する温存療法-治療限界への考察. 産婦人科の実際1997;46:855-860

• 20) Sugimoto O:A Color Atlas of Hysteroscopy. 1999, Springer-Verlag, Tokyo

• 21) 植木 實:コルポスコピー入門と応用. 1998, 永井書店, 大阪

• 22) 増淵一正:子宮頸癌の早期診断に関する研究. 日本産科婦人科学会雑誌, 1972;24:663-672

• 23) 日本子宮頸部病理・コルポスコピー学会 (編):コルポスコピー標準図譜. 1960, 中外医学社, 東京

• 24) 栗原操寿:子宮頸部の前癌病変に関する研究. 日本産科婦人科学会雑誌1972;24:663-672

• 25) 野田起一郎:子宮頸部上皮の癌化防止に関する研究. 日本産科婦人科学会雑誌1975;27:735-744

• 26) 栗原操寿:産婦人科シリーズNo 29, 腔拡大鏡診. 1980;pp10-12, 南江堂, 東京

• 27) 杉森甫, 柏村. 正道:コルポスコピーの実際. 1981, 金原出版, 東京

• 28) 日本子宮頸部病理・コルポスコピー学会 (編):改訂コルポスコピー標準図譜. 1997, 中外医学社, 東京

• 29) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会 (編):子宮頸癌取扱い規約, 改訂第2版. 1997, 金原出版, 東京室外外国文献

• 30) Hinselmann H:Improved instrumental technic for inspection of vulva and cervix. Munchen Med Wochenschr 1925;72:1733

• 31) Glathaar E:Kolposkopic in Seitz-Amreich:Biologie und Pathologic des Weides Bd III 1955, Urban & Schwarzellberg, Munchen

• 32) Ganse R:Einfuhrung in dir Kolposkopie. 1966, Fischer, Jena

• 33) Coppleson M, Pixly F, Reid B:Colposcopy:A Scientific and Practical Approach to the Cervix in Health and Disease. 1971, Thomas, Springfield

• 34) Kolstad P, Stafi A:Atlas of Colposcopy. 1972, Universitets Forlaget, Oslo

• 35) Mestwerdt G, Wespi HJ:Atlas der Kolposkopie, 4th ed. 1974, Fischer, Stuttgart

• 36) Kolstad P, Stafi A:Atlas of Colposcopy. 1977, Universitets Forlaget, Oslo

• 37) International Federation of Cervical Pathology and Colposcopy:New nomenclature for colposcopy. Obstet Gynecol 1976;48:123-124

• 38) Starfl A, Wilbanks GD:International terminology of colposcopy. The Cervix & I. f. g. t. 1991;9:91-103

P.158 掲載の参考文献

• 1) 日本癌治療学会:日本癌治療学会・癌規約総論. 1991, 金原出版, 東京

• 2) 坂本穆彦:生検組織診の意義. Medicina 1994;31:177-182

• 3) 坂本穆彦:組織診と細胞診. 病理と臨床1998;16:906-908

• 4) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会 (編):子宮頸癌取扱い規約, 改訂第2版. 1997, 金原出版, 東京

• 5) Scully RE, Bonfiglio TA, et al:Histological Typing of Female Genital Tract tumours. 2nd ed. 1994. Springer-Verlag, Berlin, Heidelberg. New York

• 6) Shepherd, JH:Staging announcement. FIGO staging ofgynecologic cancers;Cervical and vulva. Int J Gynecol Cancer 1995;5:319

• 7) 加来恒寿:検体の種類と採取の実際. 病理と臨床1998;16:497-503

• 8) 坂本穆彦:細胞診検査. 臨床検査ガイド1999〜2000 (Medical Practice編集委員会, 編). 1999;pp1005-1010, 文光堂, 東京

• 9) 飯原久仁子:検体の切り出し法と診断に役立つ特殊検査. 病理と臨床1998;16:504-508

• 10) 坂本穆彦, 土田里香, 山内直子:組織診に利用される腫瘤マーカー. 臨床婦人科産科1998;52:173-175

• 11) zur Hausen H:Human papillomavirus and their possible role in squamous carcinomas. Curr Top Microbiol Immuttnol 1997;78:1-30

• 12) 坂本穆彦, 吉川祐之:婦人科悪性腫瘍の病理-初期病変と境界病変 (癌発生のメカニズム). 癌の臨床1990;42:3-8

• 13) Konno R, Sato S, Yajima A:Progression of squamous cell carcinoma of the uterine cervix from cervical intraepithelial neoplasia in fected with human papillomavirus:A retrospective follow-up study by in situ hybridization and polymerase chain reaction. Int Gynecol Pathol 1992;11:105-112

• 14) Iihara K, Sakamoto A, et al:Cervical human papillomavirus infection in Japanese women as detected by in situ hybridization:A clinical follow up study. The Cervix 1993;11:83-88

• 15) 今野良, 佐藤信二, 矢嶋聰:ヒトパピローマウイルス感染と子宮頸部病変. 病理と臨床 1998;16:509-515

• 16) 坂本穆彦:新しい病理学的組織分類と診断基準-扁平平皮病変の新しい考え方. 産婦人科の実際 1998;47:173-179

• 17) 坂本穆彦:子宮頸癌の新組織分類. 日本婦人科腫瘍学会雑誌1999;16:138-143

• 18) Richart RM:Influence of diagnostic and therapeutic procedures on the distribution of cervical intraepithelial neoplasia. Cancer 1966;19:1635-1638

• 19) Kurman RJ, Solomon D:The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. 1994. Springer-Verlag, Berlin. Heidelberg, New York

• 20) 坂本穆彦:子宮頸癌における早期間質浸潤の問題点. 産婦人科の世界1994;46:275-279

• 21) 坂本穆彦:子宮頸部異形成・上皮内癌・微小浸潤扁平上皮癌の鑑別とその意義. 病理と臨床1998;16:516-520

• 22) 山内直子:子宮頸部腺系病変の診断. 病理と臨床1998;16:521-526

P.168 掲載の参考文献

• 1) FIGO:Amlual Report on the Results of Treatment in Gynecological Cancer. vol 18. 1982. Elseier. Stockholm

• 2) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会 (編):子宮頸癌取扱い規約. 1987, 金原出版, 東京

• 3) FIGO:Annual Report on the Result of Treatment in Gynecological Cancer. vol. 23, Journal of Epidemiology and Biostatistics 1998;3:5-34

• 4) UICC:TNM Classification of Malignant Tumours, 5th ed. 1997, Wiley-Liss, New York

• 5) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会 (編):子宮頸癌取扱い規約, 改訂第2版. 1997, 金原出版, 東京

• 6) Creasmann WT:Editorial. New gynecologic cancer staging. Gynecol Oncol 1995;58:157-158

• 7) 日本産科婦人科学会会告. 日本産科婦人科学会雑誌1997;149 (4):1113

P.178 掲載の参考文献

• 1) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会(編):子宮頸癌取扱い規約, 改訂第2版. 1997;pp5-6, 金原出版, 東京

• 2) Mayr NA, Tali ET, et al:Cervical cancer:Application of MR imaging in radiation therapy. Radiology 1993;189:601-608

• 3) Iwamoto K Kigawa J, et al:Transvaginal ultrasonographic diagnosis of bladder-wall invasionn patients with cervical cancer, Obstet Gynecol 1994;83:217-219

• 4) Yang WT, Walkden SB, et al:Transrectal ultrasound in the evaluation of cervical carcinoma and comparison with spiral computed tomography and magnetic resonance imaging. Br J Radiology 1996;69:610-616

• 5) Janus CL, Mendelson DS, et al:Staging of cervical carcinoma:Accuracy of magnetic resonance imaging and computed tomography. Clin imaging 1989;13:114-116

• 6) Kim SH, Choi BL et al:Uterine cervical carcinoma:Comparison of CT and MR lindings. Radiology 1990;175:45-51

• 7) Cobby M, Browing J, et al:Magnetic resonance imaging, computed tomography and endosonography in the local staging of carcinoma of the cervix, Br J Radiol 1990;63:673-679

• 8) Kim SH, Choi BL et al:Preoperative staging of uterine cervical carcinoma:Comparison of CT and MRI in 99 patients. Comput Assist Tomogr 1993;17:633-640

• 9) Subak L, Hricak H, et al:Cervical carcinoma:Computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 1995;86:43-50

• 10) Togashi K, Nishimura K, et al:Carcinoma of the cervix:Staging with MR imaging. Radiology 1989;171:245-251

• 11) Hricak H, Lacey CG, et al:Invasive cervical carcinoma:Comparison of MR imaging and surgical fingings Radiology. 1988;166:623-631

P.185 掲載の参考文献

• 1) Gold P, Freeman SO:Demonstration of tumor specific antigens in human colon carcinomata by immunological tolerance and absorption techniques. Exp Med 1965;121:439-462

• 2) Kato H, Torigoe T:Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977;40:1621-1628

• 3) Bast RC Jr. Feeney M, et al:Reactivity of amonoclonal antibody with human ovarian carcinoma. J Clin Invest 1981;68:1331-1337

• 4) Suminami Y, Kishi F, et al:Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem Biophys Res Commun 1991;181:51-58

• 5) Schneider SS, Schick C, et al:As erine proteinase inhibitor locus at 18q21. 3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci USA 1995;92:3147-3151

• 6) Kato H:Squamous cell carcinoma antigen. Serological Cancer Marker (Sell S, ed). 1992;pp437-451. Humana Press. Totowa

• 7) 西村隆一郎, 長谷川和男:hCGβ-core fragment. 腫瘍マーカー. 1995;pp114-119, メジカルビュー社, 東京

• 8) 加藤 紘:女性性器系悪性腫瘍. 日本臨牀 1996;54:1637-1641

• 9) Hayes DF, Bast RC, et al:Tumor marker utility grading system:A framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst 1996;88:1456-1466

• 10) Bast RC, Desch CE, et al:1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. J Clin Oncol 1998;16:793-795

• 11) 加藤 紘, 縄田修吾, 津永長門:腫瘍マーカーの細胞生物学的意義-SCC抗原を中心として. 腫瘍マーカー. 1995;pp78-84, メジカルビュー社, 東京

• 12) Kato H:Expression and function of squamous cell carcinoma antigen. Anticancer Res 19961 16:2149-2154

• 13) 村上明弘, 住浪義則, 加藤紘:末梢血中扁平上皮癌細胞の出現と血中SCC抗原mRNA. 産婦人科の世界 1998;50:475-478

P.197 掲載の参考文献

• 1) Sandritter W, Cramer H, et al:Zur Krebsdiagnostik an vaginalen Zerausstrichen mittels cytophotometrischen Messungen. Arch Gynecol 1960;192:293-303

• 2) Nishiya I, Kikuchi T, et al:Cytophotometric study of premalignant and malignant cells of the cervix in an approach towards automated cytology. Acta Cytol 1977;21:271-275

• 3) Darzynklewicz Z, Robinson J, Crissman H:Flow cytometry, 2nd ed. Part A & B. 1994;p41, Academic Press. San Diego

• 4) 西谷 巌:Image cytometry & Flow cytometry. 組織細胞化学 (日本組織細胞化学会, 編). 1995;pp2833, 学際企画, 東京

• 5) Wied GL Bartels PH, et al:Rapid high-resolution cytometry. Anal euant Cytol Histol 1982;4:257-262

• 6) Ploem JS, Verwoerd N, et al:An automated microscope for quantitative cytology combiningelevision image analysis and stage scanning microphotometry. J Histochem Cytochem 1979;27:136-143

• 7) Tucker JH:Cerviscan An image analysis system for experiments in automatic cervical smear prescreening. Comput Biomed Res 1976;9:93-107

• 8) 田中 昇, 池田栄雄, 上野哲夫, ほか:細胞診のロジックと自動化. 臨床検査1983;127:481-491

• 9) Izutsu T, Kagabu T, Nishiya I:Diagnosis of benign and malignant cervical specimens by multifiberoptic microspectrophotometry and flow cytometry. Anal Quant Cytol Histol 1989;11:196-202

• 10) Wilbur DC, Bonfiglio T A, et al:Sensitivity of the AutoPap 300 QC system fbr cervical cytologic abnormalities:Biopsy data confirmation. Acta Cytol 1996;40:127-132

• 11) Patten SF, Lee JSJ, Nelson AC:Neo Path AutoPap 300 automatic Pap screener system. Acta Cytol 1996;40:45-52

• 12) Kok MR, Boon ME:Consequences of neural network technology for cervical screening. Cancer 1996;78:112-117

• 13) Wilbur DC, Cibas ES, et al:Clinical trials demonstrate an increased detection rate of abnormalervical cytologic specimens. Am J Clin Pathol 1994;101:209-214

• 14) 小路武彦, 中根一穂:非放射性in sittt hybridization(ISH). 組織細胞化学 (日本組織細胞化学, 編). 1995;pp139-147, 学際企画, 東京

• 15) 堤 寛:In situ hybridization 法の感染症領域における展開. 臨床検査1998;42:969-977

• 16) Ishii K, Katsuyama T, et al:Cytologic and cytochemical features of adenoma malignum of the uterine cervix, Cancer Cytopathology 1999;87
  pubmed

• 17) Pinkel D, Sakamoto M, et al:Application of fluorescence in situ hybridization to detection of chromosomal aberrations. Cytometry Research 1992;2:1-11

• 18) Segers P, Haesen S, et al:Detection of premalignant stage in cervical smears with a biotinylatedrobe for chromosome 1. Cancer Genet Cytogenet 1994;75:120-129

• 19) 西谷 巌, 針生秀樹, 松田壮正:子宮頸部境界悪性病変. FISH法, CGH法の応用. 臨床婦人産科1996;50:994-1000

• 20) Kallioniemi A, Kallioniemi O-P, et al:Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-821

• 21) 坂本 優, 坂本宙子, ほか:Comparative genomic hybridization (CGH)法によるゲノム異常解析-がん診断への応用. Biotherapy 1997;11:1153-1161

• 22) 西谷 巖, 松田壯正, 吉崎陽:新しい細胞自動解析装置 -Laser Scanning Cytometer. 組織培工学1998;24:517-520

P.221 掲載の参考文献

• 1) 厚生省がん検診の有効性評価に関する研究班:がん検診の有効性等に関する情報提供のための手引 (抜粋). 1998

• 2) Hinselmann H:Zur Kenntnis der pracancerosen Veranderungen des Portio. Zbl Gynak 1927;51:901-903

• 3) Hinselmann H:Einfuhrung in die Kolposkopie. 1933, Hartung, Hamburg

• 4) Papanicolaou GN, Traut F:The diagnostic value of vaginal smear in carcinoma of the uterus. Am J Obstet Gynecol 1941;42:193-206

• 5) Papanicolaou GN, Traut F:Diagnosis of Uterine Cancer by the Vaginal Smear. 1943, Common Wealth Fund. New York

• 6) 石川正臣:腟内容の形態学的研究. 日本産科婦人科学会雑誌1950;2:167-182

• 7) 増淵一正:子宮頸癌の早期診断に関する研究. 日本産科婦人科学会雑誌1959;11:567-586

• 8) 日本母性保護医協会がん対策委員会, がん対策部:研修ノート「子宮がん検診」. 1978, 日本母性保護医協会, 東京

• 9) 日本産科婦人科学会婦人科癌検診問題委員会:委員会報告, 本邦における子宮頸癌検診の現時点での基準. 日本産科婦人科学会雑誌1978;30:407-409

• 10) 日本産科婦人科学会癌検診問題委員会:ガイドライン, 子宮頸癌の二次検診. 日本産科婦人科学会雑誌1984;36:2161-2164

• 11) 日本母性保護医協会がん対策委員会, がん対策部:老人保健法と子宮がん検診. 1984, 日本母性保護医協会, 東京

• 12) 日本母性保護産婦人科医会がん対策委員会, がん対策部:子宮がん検診の手引き. 1997, 日本母性保護産婦人科医会, 東京

• 13) Peters RK, Thomas D, et al:Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angels Country. J Natl Cancer Inst 1986;77:1063-1077

• 14) 日本臨床細胞学会 (編):細胞診用語解説集. 1996, 医学書院, 東京

• 15) The Bethesda System for reporting cervical/vaginal cytologic diagnosis. Acta Cytol 1993;37:115-124

• 16) ベセスダシステム検討小委員会報告-ベセスダシステムの本邦における対応について. 日本臨床細胞学会雑誌1993;32:1166-1168

• 17) 厚生省保健医療局疾病対策課 (編):数字でみるがん'90-第5次悪性新生物実態調査報告. 1990, 総合医学社, 東京

• 18) 厚生省大臣官房統計情報部 (編):老人保健事業報告. 1984〜1997, 厚生統計協会, 東京

• 19) Brinton LA, Tashima KT, et al:Epidemiology of cervical cancer by cell type. Cancer Res 1987;47:1706-1711

• 20) Sigurdsson K:Quality assurance in cervical cancer screening:The lcelandic experience 1964-1993. Eur J Cancer 1995;31:728-734

P.236 掲載の参考文献

• 1) 半藤 保:子宮頸部扁平上皮癌. 産婦人科学書3, 婦人科腫瘍学 (森崇英, ほか編). 1994;pp330-361, 金原出版, 東京

• 2) 平林光司:子宮頸癌に対するNeoadjuvant chemotherapy. 産科と婦人科1993;60:1299-1304

• 3) 笠松達弘, 中西 敬:放射線療法. 現代産科婦人科学大系8E, 子宮頸癌. 1970;pp353-431, 中山書店, 東京

• 4) FIGO Annual Report on the Results of Treatment in Gynaecological Cancer J Epidemiol Biostatistics 1998;3:5-34

• 5) 岩井正二;小林 隆, 泉 陸一:術前検査. 現代産科婦人科学大系8E, 子宮頸癌. 1970;pp81-98, 中山書店, 東京より引用

• 6) Boyce J, Fruchter RG, et al:Prognostic factors in stage I carcinoma of the cervix. Gynecol Oncol 1981;12:154-165

• 7) Chung CK, Nahhas WA, et al:Analysis of factors contributing to treatment failures in stage Ib and IIa carcinoma of the cervix. Am J Obstet Gynecol 1980;138:550-556

• 8) Martinbeau PW, Kjorstad KE, Iversen T:Stage Ib carcinoma of the cervix, The Norwegian Radium Hospital. II. Results when pelvic nodes are involved, Obstet Gynecol 1982;60:215-218

• 9) Inoue T, Chihara T, Morita K:Postoperative extended-field irradiation in patients with pelvic and/or common iliac node metastases from cervical carcinoma stage Ib to IIb. Gynecol Oncol 1986;25:234-243
  pubmed

• 10) Inoue T, Okumura M:Prognostic significance of pararnetrial extension in patients with cervical carchnoma stage Ib, IIa and IIb. Cancer 1984;54:1714-1719

• 11) Bleker OP, Ketting BW, et al:The significance of microscopic involvement of the parametrium and/or pelvic lymph nodes in cervical cancer stage IB and IIA. Gynecol Oncol 1983;16:56-62
  pubmed

• 12) Averette HE, Ford Jr JH, et al:Staging of cervical cancer. Clin Obstet Gynecol 1975;18:215

• 13) Koehler PR:Current status of lymphangiography in patients with cancer. Cancer 1976;37:503-516

• 14) Morrow CP:Panel report:Is pelvic irradiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastases treated by radical hysterectomy and pelvic lymphadenectomy? Gynecol Oncol 1980;10:105-110

• 15) 白水健士, 石本一也, ほか:子宮頸癌の術後放射線療法の適応と予後-予後からみた適応の再検討. 産科と婦人科1993;60:1265-1270

• 16) 堀井高久, 光本隆吉, ほか:子宮頸癌の術後放射線療法の適応と予後-頸癌術後照射の適応とその意義. 産科と婦人科1993;60:1280-1284

• 17) 田村博昭, 中井庸二, ほか:子宮頸癌の術後放射線療法の適応と予後-術後照射の有用性について. 産科と婦人科1993;60:1273-1279

• 18) 嘉村敏治:子宮頸癌の術後放射線療法の適応と予後-術後放射線療法の有用性について. 産科と婦人科1993;60:1261-1264

• 19) Glucksmann A, Cherry CP:Incidence, histology, and response to radiation of mixed carcinomas (adenoacathomas)of the uterine cervix. Cancer 1956;9:971-979

• 20) Shingleton HM, Gore H, et al:Adenocarcinoma of the cervix. I. Clinical evaluation and pathologic features. Am J Obstet Gynecol 1981;139:799-814

• 21) 日本産科婦人科学会子宮癌委員会:全国子宮頸癌調査成績 第6報, 昭和58年度症例. 1995

P.251 掲載の参考文献

• 1) Okabayashi H:Radical abdominal hysterectomy for cancer of the cervix uteri. Surgey, Gynecology and Obstetrics 1921;33:335-341

• 2) Yagi H:Extended abdominal hysterectomy with pelvic lymphadenectomy for carcinoma of the cervix. Am J Obstet Gynecol 1955;69:33-47

• 3) 夏口 操:子宮頸癌の系統的根治手術. 1974, 南江堂, 東京

• 4) 東条伸平:子宮頸癌の基本手術. 1981, 永井書店, 大阪

• 5) 荻野久作:私の行ないつつある子宮頸部癌の広汎性別出術式 (岡林術式荻野変法). 手術1950;4:160-173

• 6) 小林 隆:子宮頸癌手術. 1961, 南山堂, 東京

• 7) 小林 隆:子宮頸癌の治療. 現代産科婦人科学大系8E, 子宮頸癌. 1970;pp215-254, pp325-346, 中山書店, 東京

• 8) 坂元正一, 松沢真澄:子宮頸癌手術 (I〜V). 産婦人科治療1970;20:81-90, 259-275, 369-381, 497-505, 610-615

• 9) 坂元正一, 松沢真澄:子宮頸癌手術 (VI). 産婦人科治療1972;24:6-19

• 10) Sakamoto S:Radical hysterectomy with pelvic lymphadenectomy-The Tokyo method. Gynecol Oncol 1981;2:877-886

• 11) 野田起一郎:広汎子宮全摘出術における骨盤神経叢温存について. 日本産科婦人科学会雑誌 1985;37:313-317

• 12) 小嶺信一郎, 杉森甫, ほか:広汎性子宮全摘術後の神経因性膀胱の予防-術中電気刺激による骨盤神経叢の同定と温存. 西日本泌尿器科 1989;51:365-369

• 13) 桑原慶紀, 鈴木正明:膀胱子宮靱帯の処理, 図説産婦人科VIEW30, 子宮頸癌の根治手術. 1998;pp106-119, メジカルビュー社, 東京

• 14) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会 (編):子宮頸癌取扱い規約, 改訂第2版. 1997, 金原出版, 東京

• 15) 水谷勝美, 植田国昭, ほか:進行子宮頸癌の集学的治療-傍大動脈リンパ節転移の様式と治療について. 産科と婦人科1992;59:1335-1344

• 16) 水谷勝美, 植田国昭, ほか:傍大動脈リンパ節郭清による子宮頸癌の後腹膜リンパ節転移様式と予後. 産婦人科の世界1997;49:473-479

• 17) Jones WB:Surgical approaches for advanced or recurrent cancer of the cervix. Cancer 1987;60:2094-2103

• 18) Christopherson WA, Buchsbaum HJ:The influence of pretreatment celiotomy and paraaortic lymphadenectomy on the management of advanced stage squamous cell carcinoma of the cervix. Eur J Gynecol Oncol 1987;8:90-98

• 19) 塚本直樹:子宮頸癌のリンパ節転移. 医学のあゆみ1991;156:244-246

• 20) 桜木範明, 藤本征一郎, ほか:子宮頸癌における傍大動脈リンパ節転移について. 日本産科婦人科学会雑誌1990;42:60-66

• 21) 森下義夫, 森 崇英, ほか:子宮頸癌根治手術における超音波手術用吸引装置 (CUSA)の使用. 癌と化学療法1987;14:1494-1500

• 22) 植田国昭:CUSA. 産婦人科の実際1990;39:327-329

• 23) 西村敏雄:子宮頸癌と骨盤内リンパ節転移. 産婦人科治療1965;11:135-146

• 24) 植田国昭, 村上 章, ほか:子宮頸癌根治手術における骨盤自律神経温存法と治療成績. 産科と婦人科1994;61:95-100

• 25) 水谷勝美, 植田国昭, ほか:広汎性子宮全摘術の自律神経温存法とその意義. 産科と婦人科 1996;63:1260-1266

• 26) 吉川裕之, 植田国昭, ほか:広汎性子宮全摘出術の自律神経温存について. 産婦人科手術 1992;3:52-58

• 27) 植田国昭, 貝原 学, ほか:広汎性子宮全摘術における骨盤神経の生体染色について. 臨床婦人科産科1974;28:161-163

• 28) 植出国昭, 村上 章, ほか:広汎子宮全摘除術後の尿管障害に対する保護壁形成法の意義. 臨床婦人科産科1979;33:133-137

• 29) 植田国昭, 村上章, ほか:子宮頸癌の手術に伴う尿管狭窄・水腎症への対策. 日本外科系連合学会誌1985;12:69-71

• 30) 山中郁仁, 古谷健一, 永田一郎:広汎性子宮全摘術における骨盤腹膜縫合の有用性について. 産婦人科手術1995;6:45-51

P.259 掲載の参考文献

• 1) 橋本 清:カルチA. T. 子宮頸癌0期, Ia期に対して行う腹式準広汎性子宮全摘手術術式. 産婦人科治療1971;22:622-633

• 2) 杉森 甫:子宮頸癌Ia期の取扱い. 産科と婦人科1978;45:1132-1138

• 3) 山辺 徹:初期子宮頸癌の手術. 産婦人科治療1977;35:35-40

• 4) 藤原敏郎:子宮頸癌手術. 1984;pp117-124, 医学図書出版, 東京

• 5) 井上芳樹, 野田起一郎:準広汎子宮全摘術. 図説産婦人科VIEW30, 子宮頸癌の根治手術 (矢嶋聰, 桑原慶紀, 編). 1998;pp26-49, メジカルビュー社, 東京

• 6) Morrow CP, Curtin JP:Surgery for cervical neoplasia. Gynecologic Cancer Surgery (Morrow CP, Curtin JP, eds). 1996;pp497-499. Churchill Livingstone, New York

• 7) Piver MS:Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44:265-272

• 8) Morrow CP, Curtin JP:Tumors of the cervix. Synopsis of Gynecologic Oncology (Morrow CP, Curtin JP, eds). 5th ed. 1998;pp119-123, Churchill Livingstone, New York

• 9) Bristow RE, Karlan BY:Disorders of the uterine cervix. Dansforth's Obstetrics & Gynecology (Scott JR, DiSaia PH, et al, eds), 8th ed. 1999;pp824-825. Lippincott Williams & Wilkins, Philadelphia

• 10) 塩田 充, 小川 誠, ほか:子宮頸癌Ia期 (新規約/新進行期分類) の臨床的取扱いについて. 産科と婦人科1998;65:1141-1145

• 11) 加藤久盛, 土居大祐, ほか:子宮頸癌Ia期(新規約)の臨床的取扱いについて-新FIGO分類による分宮頸癌Ia1, Ia2期の臨床的取扱いについての検討. 産科と婦人科1998;65:1147-1152

• 12) 沼 文隆, 末広 寛, ほか:子宮頸癌Ia期 (新規約) の臨床的取扱いについて-子宮頸癌Ia期のFIGO新分類(Ia1, Ia2)について. 産科と婦人科1998;65:1155-1159

• 13) 竹島信宏, 矢納研二, ほか:子宮頸癌Ia期 (新規約) の臨床的取扱いについて-新FIGO Ia期子宮頸部扁平上皮癌の取扱い. 産科と婦人科1998;65:1160-1165

• 14) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会 (編):子宮頸癌取扱い規約, 改訂第2版. 1997;pp5-7, 金原出版, 東京

• 15) Benedet JL, Anderson GH:Stage IA carcinoma of the cervix revisited. Obstet Gynecology 1996;87:1052-1059

• 16) 小澤 満:子宮頸癌, 手術療法. 婦人科がん治療学 (野澤志朗, 大川智彦, 編). 1997;pp106-109, 金原出版, 東京

• 17) Schink JC, Lurain JR:Microinvasive cervix cancer. Int Gynaecol Obstet 1991;36:5-12

• 18) Creasman WT, Zaino RJ, et al:Early invasive carcinoma of the cervix (3 to 5 mm invasion):Risk factors and prognosis:Agynecologic oncology group study. Am J Obstet Gynecol 1998;178:62-65

• 19) Tsukamoto N, Kaku T, et al:The problem of stage Ia (FIGO 1985) carcinoma of the uterine cervix. Gynecol Oncol 1989;34:1-6

• 20) Kolstad P:Follow-up study of 232 patients with stage Ia1 and 411 patients with stage Ia2 squamous cell carcinoma of the cervix (microinvasive carcinoma). Gynecol Oncol 1989;33:265-272

• 21) Simon NL, Core H, et al:Study of superficially invasive carcinoma of the cervix. Obstet Gynecol 1986;68:19-24

• 22) Boyes DA, Worth AJ:Treatment of early cervical neoplasia:Definition and management of reclinical invasive carcinoma. Gynecol Oncol 1981;12:S317-S330

• 23) Copeland LJ, Silva EG, et al:Superficially invasive squamous cell carcinoma of the cervix. Gynecol Oncol 1992;45:307-312

• 24) Morris M, Mitchell MF, et al:Cervical conization as definitive therapy for early invasive quamous carcinoma of the cervix. Gynecol Oncol 1993;51:193-196

• 25) Burghardt E, Girardi F, et al:Microinvasive carcinoma of the uterine cervix (internationalederation of gynecology and obstetrics stage IA). Cancer 1991;67:1037-1045

• 26) 脇田邦夫, 蔵本博行, 西島正博:若年者における機能温存・機能代償, 子宮頸癌-妊孕性温存. 産科と婦人科1998;65:703-710

• 27) Fu YS, Reagan JW:Pathology of the uterine cervix, vagina, and vulva. Major Problems in Pathology, vol 21 (Bennington JL, ed). 1989;pp267-268, WB Saunders, Philadelphia

• 28) Delgado G, Bundy BN, et al:A prospective surgical pathological study of stage I squamousarcinoma of the cervix:A gynecologic oncology group study. Gynecol Oncol 1989;35:314-320

• 29) Buckley SL, Tritz DM, et al:Lymph node metastases and prognosis in patients with stage IA2 cervical cancer. Gynecol Oncol 1996;63:4-9
  pubmed

• 30) Benedetti-Panici P, Maneschi F, et al:A randomized study comparing retroperitoneal drainageith no drainage after lymphadenectomy in gynecologic malignancies. Gynecol Oncol 1997;65:478-482

P.269 掲載の参考文献

• 1) Schauta F:Die erweiterte vaginal Totalexstirpation des Uterus bei Kollumkarzinom. 1908, Verlag von Josef SAFAR, Wien, Leipzig

• 2) Schauta F:Die Operation des Gebarmtterkrebes mittels des Shuchard'shen Paravaginalschnittes. Monatschr Geburtsh Gynak 1902;15:133-152

• 3) Wertheim E:Die erweiterte abdominale Operation bei Carcinoma colli uteri auf Grund von 500 Falle. 1911, Urban & Schwarzenberg

• 4) Amreich I:Zur Anatomie und Technik der erweiterten vaginalen Carcinomoperation. 1924;Arch Gynak 122:497-553

• 5) Navratil E:Radical vaginal panhysterectomy and radical pelvic lymphadenectomy. Congress on Obstetrics and Gynaecology. 1951, CV Mosby, St Louis

• 6) Mitra S:Extraperitoneal lymphadenectomy and radical vaginal hysterectomy for cancer of the cervix (Mitra technique). Am J Obstet Gynecol 1959;78:191-196

• 7) 明石勝英, 小六義久, ほか:子宮頸癌の腟式広汎子宮全摘術に関する研究, 第3報, 腹膜外血管処理並びにリンパ節郭清の意義について. 日本産科婦人科学会雑誌1959;11:137-138

• 8) 明石勝英:腟式手術の実際-腟式子宮全摘出術を中心に. 1974;pp627-727, 金原出版, 東京

• 9) 工藤隆一, 山内 修:腹膜外リンパ節郭清ならびに腟式広汎全摘術. 産婦人科治療1988;57:245-252

• 10) 工藤隆一:腟式手術の基本と実際. 1996;pp140-169, 永井書店, 大阪

P.276 掲載の参考文献

• 1) 三林隆吉:三林術式-腹式超広汎性子宮全摘除術. 現代産科婦人科学大系8E, 子宮頸癌. 1970;pp269-279, 中山書店, 東京

• 2) 明石勝英:明石術式系統的腹膜外・膣式超広汎性子宮全摘除術. 現代産科婦人科学大系8E, 子宮頸癌. 1970;pp281-324, 中山書店, 東京

• 3) 荻野久作:私の行いつつある子宮頸部癌広汎性別出術式 (岡林術式荻野変法). 手術1950;4:160-173

• 4) 小林 隆:子宮頸癌手術. 1961, 南山堂, 東京

• 5) 東条伸平:子宮頸癌の基本手術. 1981, 永井書店, 大阪

P.284 掲載の参考文献

• 1) Brunschwig A:Complete excision of pelvic viscera for advanced carcinoma. Cancer 1948;1:177-183

• 2) Mikuta JJ:Historical development of radical surgery for cancer of the cervix. Cervical Cancer and Preinvasive Neoplasia (Rubin SC, Hoskins WJ, eds). 1996;pp183-188, Lippincott-Raven, Philadelphia, New York

• 3) Bricker EM:Bladder substitution after pelvic evisceration, Surg Clin North Am 1950;30:1511-1521

• 4) Nelson J:Transverse colon conduit. Atlas of Radical Pelvic Surgery (Nelson J, ed). 1969;pp181-191, Appleton-Century-Crofts, New York

• 5) Penalver MA, Bejany DE, et al:Continent urinary diversion in gynecologic oncology. Gynecol Oncol 1989;34:274-288

• 6) Hatch KD, Shingleton HM, et al:Low rectal resection and anastomosis at the time of pelvic exenteration. Gynecol Oncol 1988;32:262-267

• 7) Hatch KD, Gelder MS, et al:Pelvic exenteration with low rectal anastomosis:Survival, complications, and prognostic factors. Gynecol Oncol 1990;38:462-467

• 8) McCraw JB, Massey FM, ed al:Vaginal reconstruction with gracilis myocutaneous Haps. Plast Reconstr Surg 1976;58:176-183

• 9) Dudrick SJ, Wilmore DW, et al:Longterm parenteral nutrition with growth development and positive nitrogen balance. Surgey 1968;64:134-142

• 10) 塚本直樹, 松隈敬太, ほか:子宮頸癌進行例に対する骨盤除臓術. 産科と婦人科1987;54:1093-1100

• 11) 塚本直樹, Homesley HD:アメリカにおける頸癌手術の動向. 図説産婦人科VIEW 30, 子宮頸癌の根治手術. 1998;pp20-25, メジカルビュー社, 東京

• 12) 西村敏雄:子宮頸癌に対するPelvic Exenteration (骨盤臓器剔手術). 日本産科婦人科学会雑誌 1965;17:453-459

• 13) Magrilia JF:Types of pelvic exenterations. Are appraisal. Gynecol Oncol 1990;37:363-366

• 14) DiSaia PJ, Creasman WT:Clinical Gynecologic Oncology, 3rd ed. 1989;pp118-127, CV Mosby. St Louis

• 15) Deckers PJ, Ketcham AS, et al:Pelvic exenteration for primary carcinoma of the uterine cervix. Obstet Gynecol 1971;37:647-659

• 16) Shingleton HM, Orr JW:Cancer of the Cervix. 1995;pp259-294, JB Lippincott, Philadelphia

• 17) 塚本直樹, 鶴地伸宏:前斜角筋リンパ節の生検. 産婦人科の実際1994;43:161-165

• 18) Miller B, Morris M, et al:Aborted exenterative procedures in recurrent cervical cancer. Gynecol Oncol 1993;50:94-99

• 19) Morley GW, Hopkins MP, et al:Pelvic exenteration, University of Michigan:100 patients at 5 years. Obstet Gynecol 1989;74:934-943

• 20) Rutledge FN, Smith JP, et al:Pelvic exenteration:Analysis of 296 patients. Am J Obstet Gynecol 1977;129:881-892

• 21) 塚本直樹:婦人科における腸管を使用した尿路変更術. 産婦人科治療1988;57:608-614

• 22) Shingleton HM, Soong SJ, et al:Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 1989;73:1027-1034

P.306 掲載の参考文献

• 1) Fletcher GH:Textbook or Radiotherapy, 3rd ed. 1980. Lea & Febiger, Philadelphia

• 2) Moss WT, Cox JD:Radiation Oncology, 6th ed. 1989, CV Mosby, St Louis

• 3) Perez T, Brady LW:Principles and Practice of Radiation Oncology. 1987, JB Lippincott, Philadelphia

• 4) ICRU Reports 38:Dose and Volume Specification for Reporting Intra-Cavitary Therapy in Gynecology. 1985

• 5) 大川智彦, 喜多みどり:Selectron (Nucletron社) による子宮頸癌腔内照射の実際. 新しい密封小線源治療マニュアル. 1989;pp59-63

• 6) Leborgne E Fowler JF, et al:Fractionation in medium dose rate brachytherapy of cervical cancer. Int J Radiat Oncol Biol Phys 1996;35:907-914

• 7) Patel FD, Negi PS, et al:Dose rate collection in medium dose rate brachytherapy for carcinoma cervix. Radiother Oncol 1998;49:317-323

• 8) Henschke UK, Hilaris BS, Mahan GD:Remote after loading with intracavitary applicators. Radiology 1964;83:344-345

• 9) 荒居竜雄, 赤沼篤夫, ほか:子宮頸癌の放射線治療基準. 癌の臨床1984;30:496-500

• 10) 大川玲子, 荒居竜雄, ほか:子宮断端癌放射線療法の検討. 癌の臨床1979;25:1066-1073

• 11) 塚本直樹, 斎藤俊章, ほか:子宮頸癌の傍大動脈リンパ節転移に関する検討. 癌の臨床1988;34:57-62

• 12) Lagasse LD, Creasman W, et al:Results and complications of operative staging in cervical cancer:Experience of the gynecologic oncology. Gynecol Oncol 1980;9:90-98

• 13) Haie C, Pejovic A, et al:Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotheraphyroup. Radiother Oncol 1988;11:101-112

• 14) Rotman M, Choi K, et al:Prophylactic irradiation of the para-aortic lymph node chain in stage 1B and bulky stage IB carcinoma of the cervix, initial treatment results of RTOG 7920. Int J Radiat Oncol Biol Phys 1990;19:513-521

• 15) Blookland RK, Rubin S, Danoff BF:Extended field irradiation in the treatment of patients with cervical carcinoma involving biopsy proven para-aortic nodes. Int J Radiat Oncol Biol Phys 1984;10:1875-1879

• 16) Kottmeier HL, Gray M:Rectal and bladder injuries in relation to radiation dosage in carcinoma of the cervix. Am J Obstet Gynecol 1961;82:74-82
  pubmed

• 17) 荒居竜雄, 森田新六, 栗 明:子宮頸癌放射線治療による局所障害-低線量率および高線量率腔内照射の相違について. 癌の臨床1976;22:1417-1423

• 18) 森田新六, 荒居竜雄, ほか:子宮頸癌放射線治療におけるS状結腸障害-高線量率腔内照射施行例の検討. 癌の臨床1979;25:32-39

• 19) 田崎瑛生:日常診療に於ける子宮頸癌腔内照射の2, 3の問題点. 産科と婦人科1966;5:641-654

• 20) Todd MC Meredith WJ:A dosage system for use in the treatment of cancer of the uterine cervix. Br J Radiol 1938;11:809-824

• 21) Todd MC, Meredith WJ:Treatment ofcancer of the cervix:A revised "Manchester method". Br J Radiol 1953;26:252-257

• 22) 田崎瑛生, 荒居竜雄, 尾立新一郎:子宮頸癌腔内照射用支持器について. 臨床放射線1965;10:768-775

• 23) 荒居竜雄, 森田新六, ほか:高線量率腔内照射による子宮頸癌の放射線治療-至適線量と分割回数の関連性. 癌の臨床1979;25:605-612

• 24) Shigematu Y, Nishiyama K, et al:Treatment of carcinoma of the uterine cervix by remote afterloading controlled afterloading intracavitary radiotherapy with high-dose rate:A comparative study with low-dose rate system. Int J Radiat Oncol Biol Phys 1983;9:351-356

• 25) Himmelmann A, Holmberg E, et al:Intracavitary irradiation of carcinoma of the cervix stage IB and IIA. A clinical comparison between a remote high dose-rate afterloading system and a low dose-rate manual system. Acta Radiol 1985;24:139-144

• 26) Shu-Mo C, Xiang-E W, Qi W:High dose-rate afterloading in the treatment of cervical cancer of the uterus. Int J Radiat Oncol Biol Phys 1989;16:335-338

• 27) Akine Y, Tokita N, et al:Dose equivalence for high-dose rate to low dose-rate intracavitary irradiation in the treatment of cancer of the uterine cervix. Int J Radiat Oncol Biol Phys 1990;19:1511-1514

• 28) Fu KK, Phillips TL:High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1990;19:791-796

• 29) Orton CG, Seyedsadr M, Somnay A:Comparison of high and low dose rate remote afterloading for cervix and the importance of fractionation. Int J Radiat Oncol Biol Phys 1991;21:1425-1434

• 30) Arai T, Nakano T, et al:High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. Cancer 1992;69:175-180

• 31) Patel FD, Sharma S, et al:Low dose rate vs high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix:A clinical trial. Int J Radiat Oncol Biol Phys 1994;28:335-341

• 32) Okawa T, Sakata S, et al:Comparison between high dose rate and low dose rate brachytherapy for cervical cancer:Japanese experience with treatment and complications(1975-1985). J Jpn Soc Radiol Oncol 1996;8:135-142

• 33) Petereit DG, Pearcey RP:Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer:Is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phys 1999;43:359-366

• 34) Wilkinson JM, Moore CJ, et al:The use of selectron afterloading equipment to simulate and extent the Manchester system for intracavitary therapy of the cervix uteri. Br J Radiol 1983;56:409-414

• 35) 荒居竜雄:子宮頸癌. 放射線医学大系33, 性器, 悪性リンパ腫, 骨・軟部組織, ほか. 1985;p4992, 中山書店, 東京

• 36) Okawa T, Kita M, et al:Radiation therapy alone in the treatment of carcinoma of the uterine cervix:Review of experience at Tokyo Women's Medical College (1969-1983). Int J Radiat Oncol Biol Phys 1987;13:1845-1849

• 37) 金子丑之助:日本人体解剖学. 1973, 南山堂, 東京

• 38) Volterrani F, Lombardi F:Long term results of radium therapy in cervical cancer. Int J Radiat Oncol Biol Phys 1980;6:565-570

• 39) Montana GS, Fowler WS, et al:Carcinoma of the cervix stage IB:Results of treatment with radiation therapy. Int J Radiat Oncol Biol Phys 1983;9:45-49

• 40) Kapp DS, Fischer D, et al:Pretreatment prognostic factors in carcinoma of the uterine cervix:multivariable analysis of the effect of a age, stage, histology and blood counts on survival. Int Radiat Oncol Biol Phys 1983;9:445-455

• 41) Mendenhall WM, Thar T, et al:Prognostic and treatment factors affecting pelvic control of stage Band IIA-B carcinoma of the intact uterine cervix treated with radiation therapy alone. Cancer 1984;53:2649-2654

• 42) Benstead K, Cone UJ, et al:Stage III carcinoma of cervix. The importance of increasing age and extent of parametrial infiltration. Radiother Oncol 1986;5:271-276

• 43) Montana GS, Fowler WS, et al:Analysis of results of radiation therapy for IB carcinoma of the cervix. Cancer 1987;60:2195-2200

• 44) Montana GS, Fowler WS, et al:Analysis of results of radiation therapy for II carcinoma of the cervix. Cancer 1985;55:956-962

• 45) Montana GS, Fowler WS, et al:Carcinoma of the cervix stage III. Results of raiation therapy. Cancer 1986;57:148-154

• 46) Horiot JC, Pigneux J, et al:Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidlines:A French cooperative study of 1383 cases. Int J Radiat Oncol Biol Phys 1988;14:605-611

• 47) Perez CA, Kushe RR, et al:Analysis of pelvic tumor control and impact on survival in carcinoma of the uterine cervix treated with radiation therapy alone. Int J Radiat Oncol Biol Phys 1988;14:613-621

• 48) Kim RY, Trotti A, et al:Radiation alone in the treatment of cancer of the uterine cervix:Analysis of pelvic failure and dose response relationship. Int J Radiat Oncol Biol Phys 1989;17:973-978

• 49) Hopkins MP, Morley GW:Squamous cell cancer of the cervix:Prognostic factors related to survival. Int J Gynecol Cancer 1991;1:173-177

• 50) Eifel PJ, Levenback C, et al:Time course and incidence of late complication in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1995;32:1289-1300

• 51) Barillot I, Horiot JC, et al:Carcinoma of the intact uterine cervix treated with radiotherapy alone:French cooperative study:Update and multivariate analysis of prognostic factors. Int J Radiat Oncol Biol Phys 1997;38:969-978

• 52) Newman H, James JKWJ, Smith CW:Treatment of cancer of the cervix with a high-dose rate after loading machine (The Cathetron). Int J Radiat Oncol Biol Phys 1983;9:931-937

• 53) Utley JF, Essen CEet al:High-dose-rate afterloading brachytherapy in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1984;10:2259-2263

• 54) 手島昭樹, 茶谷正史, 井上俊彦:子宮頸癌の遠隔操作式高線量率腔内照射1. 生存率, 予後因子, 死因と再発形式, 及び障害について. 日本医学放射線学会雑誌1987;47:821-828

• 55) Ito H, Kutuki S, et al:Radiotherapy for cervical cancer with high-dose-rate brachytherapy correlation between tumor size, dose and failure. Radiother Oncol 1994;31:240-247

• 56) Pechoux CL, Akine Y, et al:High dose rate brachytherapy for carcinoma of the uterine cervix:Comparison of two different fractionation regimens. Int J Radiat Oncol Biol Phys 1995;31:735-741

• 57) 兼安祐子, 喜多みどり, ほか:子宮頸癌に対する放射線治療-25年間の治療成績の変遷. 癌の生存時間研究会誌1997;17:33-36

• 58) 荒居竜雄, 森田新六, ほか:進行子宮頸癌の治療. 産科と婦人科1986;53:1387-1392

• 59) 大川智彦, 喜多みどり, ほか:子宮頸癌III期に対する放射線治療成績. KARKINOS 1990;3:403-408

• 60) Lanciano RM, Pajak TF, et al:The influence of treatment time on outcome for squamous cancer of the uterine cervix with treated with radiation:A patterns-of-care study. Int J Radiatncol Biol Phys 1993;251391-397

• 61) Petereit DG, Sarkaria JN, et al:The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 1995;32:1301-1307

• 62) Perez CA, Grigsby PW, et al:Carcinoma of the uterine cervix. I. Impact of brachytherapy on outocome of radiation therapy. Int J Radiat Oncol Biol Phys 1995;32:1275-1288

• 63) 兼安祐子, 喜多みどり, ほか:子宮頸癌放射線治療成績における治療日数の影響. 日本放射線腫瘍学会誌1996;8:236-250

• 64) 日本産科婦人科学会, 日本病理学会, 日本放射線学会 (編):放射線療法. 子宮頸癌取扱い規約, 改訂第2版. 1987;pp24-29, 金原出版, 東京

• 65) Grigsby PW, Vest ML, Perez CA:Recurrent carcinoma of the cervix exclusively in the paraaortic nodes following radiation therapy. Int J Radiat Oncol Biol Phys 1993;28:451-455

• 66) Varia MA, Bundy BN, et al:Cervical carcinoma metastatic to para-aortic nodes:Extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy:A Gynecologic Oncology Group Study. Int J Radiat Oncol Biol Phys 1998;42:1015-1023

• 67) Peckham BM, Kline JG, et al:Radiation dosage and complication in cervical cancer therapy. Am J Obstet Gynecol 1969;104:485-494

• 68) Kottmeier HL:Complications following therapy in carcinoma of the cervix and their treatment. Am J Obstet Gynecol 1964;88:854-866

• 69) Orton CG, Wolf-Rosenblum S:Dose dependence of complication rates in cervix cancer radiotherapy. Int J Radiat Oncol Biol Phys 1986;12:37-44

• 70) Montana GS, Fowler WC:Carcinoma of the cervix:Analysis of bladder and rectal radiation dose and complications. Int J Radiat Oncol Biol Phys 1989;16:95-100

• 71) Crook JM, Esche BA, et al:Dose-volume analysis and the prevention of radiation sequelae in cervical cancer. Radiother Oncol 1987;8:321-332

• 72) Joelsson I, Raf L, Soderberg G:Stenosis of the small bowel as a complication in radiation therapy of carcinoma of the uterine cervix. Acta Radiologica Therapy Physics Biology 1971;10:593-604

• 73) Nagell JR, Maruyama Y, et al:Small bowel injury following radiation therapy for cervical cancer. Am J Obstet Gynecol 1974;118:163-167

• 74) Maruyama Y, Nagell JR, et al:Radiation and small bowel complication in cervical therapy. Radiology 1974;112:699-703

• 75) Cuccia CA Bloedorn FG, Onal M:Treatment of primary adenocarcinoma of the cervix. Am J Roentgenol 1967;99:371-375

• 76) Nakano T, Arai T, et al:Radiation therapy alone for adenocarcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1996;32:1331-1336

• 77) Moberg PJ, Einhorn N, et al:Adenocarcinoma of the cervix. Cancer 1986;57:407-410

• 78) Grigsby PW, Perez CA, et al:Adenocarcinoma of the uterine cervix:Lack of evidence for a poorrognosis. Radiother Oncol 1988;12:297-300

• 79) Eifel PJ, Morris M, et al:Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases. Cancer 1990;65:2507-2514

P.316 掲載の参考文献

• 1) Schlink HH:Cancer of cervix uteri:Australian results 1930-1950. J Obstet Gynaecol Br Emp 1950;104:714-719

• 2) Kamura T, Tsukamoto N, et al:Multivariate analysis of the histopathologic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 1992;69:181-186

• 3) 喜多みどり, 唐澤久美子:子宮頸癌-手術と放射線. 婦人科がん治療学. 1997;pp115-122, 金原出版, 東京

• 4) 笠松達弘:子宮頸癌治療における術前照射. 産婦人科の実際1986;35:27-30

• 5) Guttmann R:Significance of postoperative irradiation in carcinoma of the cervix:A ten year survey. Am J Roentgenol 1970;108:102-108

• 6) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会 (編):子宮頸癌取扱い規約, 改訂第2版. 1997, 金原出版, 東京

• 7) Kamura T, Shigematu T, et al:Histopathological factors influencing pelvic lymph node metastasis in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy. Acta Obstet Gynecol Scand 1999;78:452-457

• 8) 茂松直之, 伊藤久夫, ほか:子宮頸癌術後照射の予後と合併症. J Jpn Soc Cancer Ther 1997;32:141-146

• 9) 嘉村敏治, 塚本直樹:子宮頸癌に対する広汎子宮全摘術後の全骨盤腔外部照射の治療効果. 産婦人科の実際1991;40:477482

• 10) Stock RG, Chen AS, et al:Node-positive cervical cancer:Impact of pelvic irradiation and patterns of failure. Int J Radiat Oncol Biol Phys 1995;31:31-36

• 11) Robert W, Maecus ER:Advances in gynecologic radiation oncology. Curr Opin Oncol 1997;9:471-477

• 12) James GB, Eric E, Paul H:Paraaortic lymph node biopsy:A twenty year study. Am J Obstet Gynecol 1997;176:1157-1165

• 13) 松山敏剛, 塚本直樹, ほか:子宮頸癌放射線治療前の試験開腹術 (Staging laparotomy) の検討. 日本産科婦人科学会雑誌1989;41:280-286

• 14) 村上順子, 日浦昌道, ほか:子宮頸癌における傍大動脈リンパ節転移の危険因子と郭清の適応に関する検討. J Jpn Soc Cancer Ther 1996;31:1009-1018

• 15) 堀井高久, 光本隆吉, 野田起一郎:頸癌治療における傍大動脈節照射の意義. 産科と婦人科 1987;54:1629-1635

• 16) Thomas GM, Dembo AJ:Is there a role for adjuvant pelvic radiotherapy after radical hysterectomy in early stage cervical cancer? Int J Gynecol Cancer 1991;1:1-18

• 17) 籾木 茂, 山口 豊, 宮本忠昭:培養Helas 3細胞におけるX線とCis-DDPの併用による効果増強に関する研究. J Jpn Soc Cancer Ther 1987;22:2352-2361

• 18) Madhu J, Marshall F, et al:Final results of phase H chemoradiation protocol for locally advanced cervical cancer:RTOG 85-15. Gynecol Oncol 1996;61:221-226

• 19) Abbie L, Patrick SA, et al:Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for local advanced squamous cell carcinoma of the cervix. Gynecol Oncol 1996;61:416-422

• 20) Keys HM, Bundy BN, et al:Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-1161

P.331 掲載の参考文献

• 1) Frei III E:Clinical cancer research:An embattled species. Cancer 1982;50:1979-1992

• 2) 山田龍作, 山口真司, ほか:新しい抗癌剤投与法-Balloon catheterによる一時的動脈閉塞下抗癌剤動注療法の開発. 日本医学放射線学会雑誌1981;41:894-896

• 3) 橋井康二, 立山一郎, ほか:進行子宮頸癌に対する動脈塞栓法併用術前動注化学療法の効果について. 日本癌治療学会誌1992;27:695-705

• 4) Buxton EJ, Meanwell CA, et al:Combination bleomycin, ifosfamide and cisplatinchemotherapy in cervical cancer. J Natl Cancer Inst 1989;81:359-361

• 5) Vogl SE, Moukhtar M, et al:Chemotherapy for advanced cervical cancer with bleomycin, vincristine, mitomycin C, and cis-diamminedichloroplatinum (II) (BOMP). Cancer Treat Rep 1980;64:1005-1007

• 6) Shimizu Y, Akiyama F, et al:Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma. J Clin Oncol 1998;16:1869-1878

• 7) Sugiyama T, Yakushiji M, et al:Phase II study of irinotecan (CPT-11) and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer. Oncology 1999 (in press)

• 8) 平林光司, 岡田悦子, ほか:進行, 再発子宮頸癌に対する254-S, Ifosfamide, Peplomycin 併用化学療法の臨床的研究. 日本産科婦人科学会雑誌1992;44:341-348

• 9) 泉 陸一:第1, 2次研究補助化学療法群のメタアナリシスによる検討成績について. 第15回婦人科がん化学療法共同研究会総会記録集, 別冊. 1998;pp44-47, トプコ出版, 東京

• 10) 梅咲直彦, 川村直樹:維持化学療法の意義. 子宮頸部腫瘍の診断と治療 (森 崇英, ほか編). 1996;pp170-178, 永井書店, 大阪

• 11) 植木 実, 前田隆義, ほか:子宮頸部癌術後患者の再発risk度別管理法とそのrisk群に対するsurgical adjuvant chemotherapyの成績. 日本癌治療学会誌1983;18:927-939

• 12) 池田正典, 手島研作, ほか:Carmofur長期投与による頸部腺癌術後補助化学療法の意義. 癌と化学療法1994;21:1967-1974

• 13) 須川 佶, 梅咲直彦, ほか:長期維持化学療法-その効果と副作用. 産婦人科の実際1986;35:1715-1719

• 14) Keys HM, Bundy BN, et al:Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-1161

• 15) Morris M, Ei fel PJ, et al:Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high risk cervical cancer. N Engl J Med 1999;340:1137-1143

• 16) Rose PG, Bundy BN, et al:Concurrent cisplatin-based radiotherapy and chemotherapy locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153

• 17) Okamura K, Suzuki M, et al:Clinical evaluation of sizofiran combined with irradiation in patients with cervical cancer. Biotherapy 1989;1:103-107

• 18) Kavanagh JJ, Gershenson D, et al:Combination chemotherapy for metastatic or recurrent adenocarcinoma of the cervix. J Clin Oncol 1987;5:1621-1623

• 19) 杉森 甫:子宮頸部腺癌の化学療法. Oncol Chemother 1993;9:99-102

• 20) 竹原正輝, 早川 修, 工藤隆一:子宮頸部腺癌の化学療法に関する基礎的・臨床的検討. 日本産科婦人科学会雑誌1995;47:405-412

• 21) Umesaki N, Izumi R, et al:Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease. Gynecol Oncol 1999;75:142-144
  pubmed

• 22) Iwasaka T, Fukuda K et al:Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix. Gynecol Oncol 1998;70:236-240

P.340 掲載の参考文献

• 1) 戸部隆吉, 前谷俊三, ほか:消化器癌の集学的治療-抗癌剤および投与法の開発 (齋藤達雄, 編). 1988;pp257-263, 医薬ジャーナル社, 大阪

• 2) FIGO:Annual Report on the Results of Treatment in Gynecological Cancer (Petterson F, ed), vol 23. 1998;pp29-43

• 3) 日本産科婦人科学会婦人科腫瘍委員会:第35回治療年報. 日本産科婦人科学会雑誌1998;50:278-305

• 4) Park RC, Thgpen T:Chemotherapy inadvanced and recurrent cervical cancer:A review. Cancer 1993;71 (suppl):1446-1450

• 5) Vermorken JB:The role of chemotherapy in squamous cell carcinoma of the uterine cervix. Int J Gynecol Cancer 1993;3:129-142

• 6) Kirsten F, Atkinson KH, et al:Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer. Br J Obstet Gynaecol 1987;94:583-588
  pubmed

• 7) Symonds RP, Burnett RA, et al:The prognostic value of a response to chemotherapy given before radiotherapy in advanced cancer of cervix. Br J Cancer 1989;59:473-475

• 8) Park TK, Chol DH, et al:Role of induction chemotherapy in invasive cervical cancer. Gynecol Oncol 1991;41:107-112

• 9) Chauvergne J, Rohart J, Heron J:Randomized phase III trial of neoadjuvant chemotherapy + radiotherapy vs radiotherapy in stage IIb, III carcinoma of cervix:A cooperative study of the French Oncology centers. Proc Annu Meet Am Soc Clin Oncol 1988;7:A524 [abstract]

• 10) Tobias J, Buxton EJ, et al:Neoadjuvant bleomycin, ifosfamide and cisplatin cervical cancer. Cancer Chemother Pharmacol 1990;26 (suppl):S59-S62

• 11) Cardenas J, Olguin J, et al:Randomized neoadjuvant chemotherapy in cervical cancer stage IIB:PEC + radiotherapy vs radiotherapy. Proc Annu meet Am Soc Clin Oncol 1991;10:A620 [abstract]

• 12) Souhami L, Gil RA, et al:Randomized trial of chemotherapy followed by pelvic radiotherapy versus radiotherapy alone in stage IIIB carcinoma of the cervix. J Clin Oncol 1991;9:970-977

• 13) Cardenas J, Olguin J, et al:Neoadjuvant chemotherapy+radiotherapy vs radiation alone in stage IIIb cervical carcinoma:Preliminary results. Proc Annu Meet Am Soc Clin Oncol 1992;11:A743 [abstract]

• 14) Tattersall MHN, Ramirez C, Coppleson M:A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer. Int J Gynecol Cancer 1992;2:244-251

• 15) Chiara S, Bruzzone M, et al:Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIb-III cervical carcinoma. Am J Clin Oncol 1994;17:294-297

• 16) Kumar L, Kaushal R, et al:Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer:A randomized study. Gynecol Oncol 1994;54:307-315

• 17) Tattersall MHN, Lorvidhaya V, et al:Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J Clin Oncol 1995;13:444-451

• 18) Sardi J, Giaroli A, et al:Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma cervix uteri:An unexpected therapeutic management. Int J Gynecol Cancer 1996;6:85-93

• 19) Sundfor K, Trope CG, et al:Randomized and neoadjuvant chemotherapy for cervical carcinoma. Cancer 1996;77:2371-2378

• 20) Kumar L, Grover R, et al:Neoadjuvant chemotherapy in locally advanced cervical cancer:Two randomized studies, Aust NZ Med 1998;28:387-390

• 21) Steel GG:The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother Oncol 1988;11:31-53

• 22) Carmichael J, Hickson ID:Keynote address:Mechanism of cellular registance to cytotoxic drugs and x-irradiation. Int J Radiat Oncol Biol Phys 1991;20:197-202

• 23) Potish RA, Twiggs LB:On the lack of demonstrated clinical benefit of neoadjuvant cisplatinum therapy for cervical cancer. Int J Radiat Oncol Biol Phys 1993;27:975-979

• 24) Sueyama H, Nakano M, et al:Therapeutic value of neoadjuvant intra-arterial chemotherapy (cisplatin) and irradiation for locally advanced uterine cervical cancer. Gynecol Oncol 1997;65:421-424

• 25) Sardi JE, Giaroli A, et al:Long term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix:The final results. Gynecol Oncol 1997;67:61-69
  pubmed

• 26) Park S-Y, Kim B-G, et al:Phase I/II study of neoadjuvant intraarterial chemotherapy with mitomycin-C, vincristine, and cisplatin in patients with stage IIb bulky cervical carcinoma Cancer 1995;76:814-823

• 27) Nagata Y, Okajima K, et al:Clinical results of transcatheter arterial infusion for uterine cervical cancer. Am J Clin Oncol 1999;22:97-102

• 28) Dewit L:Combined treatment of radiation and cis-diamminedichloro-platinum II:A review of experimental and clinical data. Int J Radiat Oncol Biol Phys 1987;13:403-426

• 29) Alberts DS, Maason Liddil N:The role of cisplatin in the management of advanced squamous cell cancer of the cervix. Semin Oncol 1989;16:66-78

• 30) Britten RA, Evans AJ, et al:Effect of cisplatin in the clinically relevant radiosensitivity of human cervical carcinoma cell lines. Int J Radiat Oncol Biol Phys 1996;34:367-374

• 31) Tseng C-J, Chang C-T, et al:A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol 1997;66:52-58

• 32) Morris M, Eitel PJ, et al:Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-1143

• 33) Rose PG, Bundy BN, et al:Concurrent cisplatin-based radiotherapy and chemotherapy fro locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153

• 34) Keys HM, Bundy BN, et al:Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 19991 340:1154-1161

• 35) Whitney CW, Sause W, et al:A randomized comparison of florouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. J Clin Oncol 1999;17:1339-1348

• 36) Peters WA III, Liu PY, et al:Cisplatin and 5 Huorouracil plus radiation therapy are superior to radiation therapy as adjunctive in high-risk early-stage carcinoma or the cervix after radical hysterectomy and pelvic lymphadenectomy:Report of a phase III intergroup study. Proc Soc Gynecol Oncol 1999;28 [Abstract]

• 37) Hilders CG, Ras L, et al:Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma. Int J Cancer 1994;57:805-813

• 38) Alexander M, Salgller ML, et al:Generation of tumor specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope. Am J Obstet Gynecol 1996;175:1586-1593

• 39) Nimako M, Fiander AN, et al:Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III. Cancer Res 1997;57:4855-4861

• 40) Borysiewicz LK Fiander A, et al:A recombinant vaccinia virus encoding human papillomavirus type 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 1996;347:1523-1527

• 41) Steller MA, Gurski KJ, et al:Cell mediated immunological responses in cervical and vaginal cancer patients immunized With a lipidated epitope of human papillomavirus type 16 E7. Clin Cancer Res 1998;4:2103-2109

P.349 掲載の参考文献

• 1) 松尾憲人, 福田耕一, ほか:子宮頸部腫瘍に対する子宮温存療法. 産婦人科の実際1994;43:647-652

• 2) 横山正俊, 杉森 甫:子宮頸部病変に対するレーザー円錐切除術. 第17回日本レーザー医学会大会論文集. 1996;pp137-140, 第17回日本レーザー医学会大会事務局

• 3) 蔵本博行, 脇田邦夫, ほか:子宮頸部早期癌に対する保存療法としての各種レーザー療法. 産婦人科の実際1995;44:931-935

• 4) Bostofte E, Berget A, et al:Conization by carbon dioxide laser or cold knife in the treatment of cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand 1986;65:199-202
  pubmed

• 5) Baggish MS, Dorsey JH Adolson M:A ten year experience treating cervical intraepithelial neoplasia with CO2 laser. Am J Obstet Gynecol 1989;161:60-68

• 6) Tabor A, Berget A:Cold knife and laser conization for cervical intraepithelial neoplasia. Obstet Gynecol 1990;76:633-635

• 7) Sagot P, Lopes P, et al:Cervical intraepithelial neoplasia III treatments by carbon dioxide laser. Eur J Obstet Gynecol Reprod Biol 1990;37:183-189

• 8) 木附公介:子宮頸部上皮内腫瘍のNd:YAGレーザー療法に関する研究. 日本癌治療学会誌 1990;25:2810-2821

• 9) 脇田邦夫, 金井督之, ほか:CIN, 治療の実際-Laser. 産科と婦人科1996;63:930-934

• 10) 松尾憲人, 岩坂 剛, ほか:子宮頸部初期病変に対するCO2レーザー円錐切除術の臨床的検討. 日本産科婦人科学会雑誌1990;42:93-98

• 11) Mathevet P, Dargent D, et al:A randomized prospective study comparing three techniques of conization:Cold knife, laser, and LEEP. Gynecol Oncol 1994;54:175-179

• 12) 永田尚夫, 佐藤和夫:レーザー治療の進歩. 産科と婦人科1992;59:501-508

• 13) 脇田邦夫, 蔵本行博, 西島正博:子宮頸癌-妊孕能温存 (とくにレーザー療法による). 産科と婦人科1998;65:703-710

• 14) 脇田邦夫, 泉 貴文, ほか:子宮頸部腫瘍に対するYAGとCO2レーザー円錐切除術の比較検討. 日本産科婦人科学会雑誌1992;44:1142-1148

• 15) Larsson G, Gullberg B, Grundsell H:A comparison of complication of laser and cold knife conization. Obstet Gynecol 1983;62:213-217

• 16) Baggish MS:A comparison between laser excisional conization and laser vaporization for the treatment of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1986;155:39-44

• 17) Hacker NF, Berek JS, et al:Carcinoma of the cervix associated with pregnancy. Obstet Gynecol 1982;59:735-74618

• 18) Hannigan EV, Whitehouse HH III, et al:Cone biopsy during pregnancy. Obstet Gynecol 1982;60:450-455

• 19) Coppola A, Sorosky J, et al:The clinical course of cervical carcinoma in situ diagnosed during pregnancy. Gynecol Oncol 1997;67:162-165

• 20) 横山正俊, 原 浩一, ほか:当科における妊娠合併子宮頸部腫瘍. 日本産科婦人科学会九州連地方部会雑誌1998;49:200-204

• 21) Goldberg GL, Altaras MM, Block B:Cone cerclage in pregnancy. Obstet Gynecol 1991;77:315-317

• 22) Moriyama M, Takahashi K, et al:Studies on the usefulness of preserving in cervical intraepithelial neoplasia (CIN) using COz laser conization. J Jpn Cancer Ther 1993;28:1886-1894

• 23) Penna C, Fallani MG, et al:High-grade intraepithelial neoplasia (CIN) in pregnancy:Clinicotherapeutic management. Tumori 1998;84:567-570

• 24) Sagot P, Caroit Y, et al:Obstetrical prognosis for carbon dioxide laser conisation of the uterine cervix. Eur J Obstet Gynecol Reprod Biol 1995;58:53-58
  pubmed

• 25) Hagen B, Skjeldestad FE:The outcome of pregnancy after CO2 laser conisation of the cervix. Br J Obstet Gynaecol 1993;100:717-720

• 26) Kristensen J, Langhoff-Roos J, et al:Cervical conization and preterm delivery/low birth weight. Acta Obstet Gynecol Scand 1993;72:640-644

• 27) Kristensen J, Langhoff-Roos J, Kristensen FB:Increased risk of preterm birth in women with cervical conization. Obstet Gynecol 1993;81:1005-1008

• 28) Svare JA, Andersen LE et al:The relationship between prior cervical conization, cervical microbial colonization and preterm premature rupture of the membranes. Eur J Obstet Gynecol Repro Biol 1992;47:41-45

• 29) Forsmo S, Hansen MH, et al:Pregnancy outcome after laser surgery for cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand 1996;75:139-143

• 30) Leiman G Harrison NA, Rubin A:Pregnancy following conization of the cervix:Complication related to cone size. Am J Obstet Gynecol 1980;136:14-18

• 31) Raio L, Ghezzi F, et al:Duration of pregnancy after carbon dioxide laser conization of the cervix:Influence of cone height, Obstet Gynecol 1997;90:978-982

P.354 掲載の参考文献

• 1) Prendiville W, Cullimore J, Norman S:Large loop excision of the transformation zone (LLETZ):A new method of management for women with cervical intraepithelial neoplasia. Br J Obstet Gynaecol 1989;96:1054-1060

• 2) Alvarez R, Helm CW, et al:Prospective randomized trial of LLETZ versus laser ablation in patients with cervical intraepithelial neoplasia. Gynecol Oncol 1994;52:175-179

• 3) Gunasekera PC, Phipps JH, Lewis BV:Large loop excision of the transformation zone (LLETZ) compared to carbon dioxide laser in the treatment of CIN:A suprior mode of treatment. Br J Obstet Gynaecol 1990;97:995-998

• 4) Chappatte OA, Byrne DL et al:Histological differences between colposcopic-directed biopsy and loop excision of the transformation zone (LETZ):A cause for concern. Gynecol Oncol 1991;43:46-50

• 5) Eddy GL, Spiegel GW, Creasman WT:Adverse effect of electrosurgical loop excision on assignment of FIGO stage in cervical cancer:Report of two cases. Gynecol Oncol 1994;55:313-317

• 6) Kennedy AW, Eltabbakh GH, et al:Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ. Gynecol Oncol 1995;58:274-277

• 7) Wright TC, Gagnon S, et al:Treatment of cervical intraepithelial neoplasia using the loop electrosurgical excision procedure. Obstet Gynecol 1992;79:173-178

• 8) Krebs HB, Pastore L, Helmkamp BF:Loop electrosurgical excision procedures for cervical dyspiasia:Experience in a community hospital. Am J Obstet Gynecol 1993;169:289-295

• 9) Bigrigg MA, Colding BW, et al:Colposcopic diagnosis and treatment of cervical dysplasia at a single clinic visit. Lancet 1990;336:229-231

• 10) Luesley DM, Cullimore J, et al:Loop diathermy excision of the cervical transformation zone in patients with abnormal cervical smears. Br Med J 1990;300:1690-1693

• 11) Whiteley PF, Olah KS:Treatment of cervical intraepithelial neoplasia:Experience with the low voltage diathermy loop. Am J Obstet Gynecol 1990;162:1272-1277

• 12) Murdoch JB, Morgan PR, et al:Histological incomplete excision of CIN after large loop excision transformation zone (LLETZ) merits careful follow up, not retreatment. Br J Obstet Gynaecol 1992;99:990-993
  pubmed

• 13) Keijser KGG, Kenemans P, et al:Diathermy loop excision in the management of cervical intraepithelial neoplasia:Diagnosis and treatment in one procedure. Am J Obstet Gynecol 1992;166:1281-1287

• 14) Eduardo AM, Dinh TV, et al:Outpatient loop electrosurgical excision procedure for cervical intraepithelial neoplasia:Can it replace cold knife conization? J Reprod Med 1996;41:729-732

• 15) 藤原 潔, 岡部一裕, 高山雅臣:CINおよび子宮頸部微小浸潤癌に対するLoop Electrosurgical Excision Procedure (LEEP) による治療法の検討. 産婦人科手術1996;7:3944

• 16) Wright TC, Richart RM, et al:Comparison of specimens removed by CO2 lazer conization and the loop electrosurgical excision procedure. Obstet Gynecol 1992;79:147-153

• 17) Nauman RW, Bell MC, et al:LLETZ is an acceptable alternative to diagnostic cold-knife conization. Gynecol Oncol 1994;55:224-228

• 18) Ferenczy A, Choukroun D, et al:The effect of cervical loop electrosurgical excision on subsequent pregnancy outcome:North American experience. Am J Obstet Gynecol 1995;172:1246-1250

P.362 掲載の参考文献

• 1) Dougherty TJ, Lawrence G, et al:Photoradiation in the treatment of recurrent breast cancer. J Natl Cancer Inst 1979;62:231-237

• 2) Hayata Y, Kato H, et al:Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest 1982;181:269-277

• 3) 天神美夫, 杉下 匡:エキシマダイレーザーを用いた光線力学治療による子宮頸癌保存療法の基礎的研究. 産婦人科治療1988;57:420-425

• 4) 天神美夫, 作永穂高, ほか:エキシマ・ダイ・レーザーを用いた光力学的治療での子宮頸癌に対する至適照射法の検討-レーザー治療用コルポスコープと頸管プローブの開発と臨床応用. 産婦人科の実際1990;39:1963-1967

• 5) 室谷哲弥, 作永穂高, ほか:PHE (Porfimer Sodium)およびExcimer Dye Laser (PDT EDL-1) による初期子宮頸癌ならびにその前癌病変に対するPhotodynamic Therapy(PDT)の臨床-第III相試験. Oncology & Chemotherapy 1992;8:302-307

• 6) 室谷哲弥, 作永穂高, ほか:Photodynamic Therapy (PDT) による初期子宮頸癌および異形成に対する保存的療法. Oncology & Chemotherapy 1993;9:21-32

• 7) 室谷哲弥, 作永穂高, ほか:Photodynamic Therapy (PDT) の臨床-コルポ診, 細胞診, 組織診における変化を含めて. 日本レーザー医学会誌1994;15:41-52

• 8) 作永穂高, 室谷哲弥, ほか:機能温存療法の現状と将来. Oncology & Chemotherapy 1994;10:1-4

• 9) 室谷哲弥, 末広 寛, ほか:早期子宮頸癌の光線力学的治療. 癌と化学療法1996;23:47-56

• 10) 室谷哲弥, 未広 寛, ほか:CINに対する子宮温存手術-光線力学治療 (Photodynamic Therapy) の治療成績. 産婦人科手術1996;7:27-38

• 11) Muroya T, Sugishita T, et al:New strategies in cancer treatment-Photodynamic therapy. The Journal of Tokyo Medical College 1997;55:408-424

• 12) 室谷哲弥, 末広 寛, ほか:子宮頸部癌に対するPDTの特性とその応用. 第18回日本レーザー医学会大会大会論文集. 1997;pp113-116

• 13) 室谷哲弥, 河崎恵子, ほか:私はこうしている-CINに対するPDT (Photodynamic Therapy) 療法. 産婦人科治療1998;77:441-443

• 14) Muroya T, Sugishita T, et al:Application and prospect of PDT for cervical cancer. Porphyrins 1998;7:187-192

• 15) Muroya T, Sugishita T, et al:Application of PDT for uterine cervical cancer. Diagnostic and Therapeutic Endoscopy 1999;5:183-190

P.368 掲載の参考文献

• 1) Method MW, Brost BC:Management of cervical cancer in pregnancy. Semin Surg Oncol 1999;16:251-260

• 2) 日本産科婦人科学会:婦人科腫瘍委員会報告. 昭和61年度子宮頸癌患者年報. 日本産科婦人科学会雑誌1992;44:1501-1502

• 3) 日本産科婦人科学会:婦人科腫瘍委員会報告. 1993年度子宮頸癌患者年報. 日本産科婦人科学会雑誌1997;49:59-60

• 4) Guerra B, De Simone P, et al:Combined cytology and colposcopy to screen for cervical cancer in pregnancy. J Reprod Med 1998;43:647-653

• 5) 吉岡忠亮, 井上芳樹, 野田起一郎:初期頸癌ならびにその関連病変の管理. 産科と婦人科 1991;58:1914-1918

• 6) Economas K, Veridiano HP, et al:Abnormal cervical cytology in pregnancy:A 17-year experience. Obstet Gynecol 1993;81:915-918

• 7) Hopkins MP, Morley GW:The prognosis and management of cervical cancer associated with pregnancy. Obstet Gynecol 1992;80:9-13
  pubmed

• 8) Campion MJ, Sedlacek TV:Colpos copy in pregnancy. Contemporary Colposcopy 1993;20:153-163

• 9) Sorosky JL Squatrito R, et al:Stage I squamous cell cervical carcinoma in pregnancy:Planned delay in therapy awaiting fetal maturity. Gynecol Oncol 1995;59:207-210

• 10) Mayr NA, Yuh WT, et al:Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer. Int J Radiat Oncol Biol Phys 1997;39:395-404

• 11) Nisker JA, Shubat M:Stage IB cervical carcinoma and pregnancy:Report of 49 cases. Am J Obstet Gynecol 1983;145:203-206

• 12) Baltzer J, Regenbrecht ME, et al:Carcinoma of the cervix and pregnancy. Int J Gynaecol Obstet 1990;31:317-323

• 13) Hanningan EV:Cervical cancer in pregnancy. Clin Obstet Gynecol 1990;33:837-845

• 14) Greer BE Easterling TR, et al:Fetal and maternal considerations in the management of stage IB cervical cancer during pregnancy. Gynecol Oncol 1989;34:61-65

• 15) Bokhman JV, Urmancheyeva AF:Cervix uteri cancer and pregnancy. Eur J Gynaecol Oncol 1989;10:406-411

• 16) Zemlickis D, Lishner M, et al:Maternal and fetal outcome after invasive cervical in pregnancy. J Clin Oncol 1991;9:1956-1961

• 17) Van der Vange N, Weverling GJ, et al:The prognosis of cervical cancer associated with pregnancy:A matched cohort study. Obstet Gynecol 1995;85:1022-1026

• 18) 大橋美佐保, 中塚幹也, ほか:子宮頸癌合併妊娠症例の妊娠継続についての検討. 日本産科婦人科学会雑誌1999;51:5157

• 19) Bostelis JG:Intraepithelial carinoma of the cervix associated, with pregnancy. Obstet Gynecol 1972;40:657-666

• 20) 藤永宏行:妊娠に合併した頸癌の取り扱い. 子宮頸部腫瘍の診断と治療(森 崇英, 椹木 勇, ほか, 編). 1996;pp185-190, 永井書店, 大阪

• 21) Hacker NF, Berek JS, et al:Carcinoma of the cervix associated with pregnancy. Obstet Gynecol 1982;59:735-747

• 22) Kristensen J, Langhoff J, Kristensen FB:Increase risk of preterm birth in women with cervical conization. Obstet Gynecol 1993;81:1005-1008

• 23) Svare JA, Langhoff J, Jenses ET:The relationship between prior cervical conization, cervical microvial colonization and preterm premature rupture of the membrane. Eur J Obstet Gynecol Reprod Biol 1992;47:41-45

• 24) 斉藤淳子, 星合 昊:妊娠と子宮頸癌-異形成と上皮内癌. 周産期医学1996;26:1655-1658

• 25) Ueki M, Ueda M, et al:Cervical cytology and conservative management of cervical neoplasias during pregnancy. Int J Gynecol Pathol 1995;14:63-69

• 26) 久布白兼行, 山下 博, ほか:妊娠時の子宮頸部初期癌と円錐切除術. 産婦人科治療1999;78:1097-1103

• 27) Creasman WT:Editorial:New gynecologic cancer staging. Gynecol Oncol 1995;58:157-158

• 28) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会(編):子宮頸癌取扱い規約, 改訂第2版. 1997, 金原出版, 東京

• 29) Creasman WT, Fetter BF, et al:Management of stage Ia carcinoma of the cervix. Am J Obstet Gynecol 1985;153:164-172

• 30) Simon NL, Gore H, et al:Study of superficially invasive carcinoma. Obstet Gynecol 1986;68:19-24

• 31) Tsukamoto N Kaku T, et al:The problem of stage Ia (FIGO 1985) carcinoma of the uterine cervix. Gynecol Oncol 1989;34:109-113

• 32) Ueki M, Okamoto Y, et al:Conservative therapy for microinvasive carcinoma of the uterine cervix. Gynecol Oncol 1994;53:1-6
  pubmed

• 33) Tseng C-J, Horng S-G, et al:Conservative conization for microinvasive carcinoma of the cervix. Am J Obstet Gynecol 1997;176:1009-1110

• 34) Morris M, Mitchell MF, et al:Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix. Gynecol Oncol 1993;51:193-196

• 35) Copeland LJ, Silva EG, et al:Superficially invasive squamous carcinoma of the cervix. Gynecol Oncol 1992;45:307-312

• 36) 薬師寺道明, 蓮尾泰之:初期子宮頸癌に対する円錐切除の評価-特に, 妊孕性の温存と. 妊娠分への影響について. 産婦人科の世界1998;50:517-521

• 37) Maiman MA, Fruchter RG, et al:Superficially invasive squamous cell carcinoma of the cervix. Obstet Gynecol 1988;72:399-403

• 38) Kolstad P:Follow-up study of 232 patients with stage IA1 and 411 patients with stage IA2 squamous cell carcinoma of the cervix (microinvasive carcinoma). Gynecol Oncol 1989;33:265-272

• 39) Buckley SL Tritz DM, et al:Lymph node metastases and prognosis in patients with stage IA2 cervical cancer. Gynecol Oncol 1996;63:4-9
  pubmed

• 40) Benedet JL, Anderson GH:Stage IA carcinoma of the cervix revisited. Obstet Gynecol 1996;84:1052-1059

• 41) National Institutes of Health Consensus Development Conference statement on cervical cancer. Gynecol Oncol 1997;66:351 361

• 42) Duggan B, Muderspach LI, et al:Cervical cancer in pregnancy:Reporting on planned delay in therapy. Obstet Gynecol 1993;82:598-602

• 43) Burgess SP, Waymont B:Implantation of a cervical carcinoma in an episiotomy site:Case report. Br J Obstet Gynaecol 1987;94:598-599

• 44) Copeland LJ, Saul PB, Sneige N:Cervical adenocarcinoma:Tumor implantation in the episiotomy sites of two patients. Gynecol Oncol 1987;28:230-235

• 45) EL-Bastawissi AY, Becker TM, Daling JR:Effect of cervical carcinoma in situ and its management on Pregnancy outcome. Obstet Gynecol 1999;93:207-212

P.384 掲載の参考文献

• 1) 赤木由紀夫, 広川 裕, ほか:QOL補正生存率を用いた局所進行食道癌の治療成績. 癌の臨床 1997;43:279-283

• 2) 日本癌治療学会癌の治療に関する合同委員会(編):I. 追跡調査総論, II. 生存率規約. 日本癌治療学会・癌規約総論. 1985;pp1-25, 金原出版, 東京

• 3) Culliton BJ:GAO report angers Cancer Officials. Science 1987;236:380-381

• 4) 池田 恢, 加賀美芳和, ほか:手段としてのQALY-KPSの提案. 癌の臨床1995;41:1209-1212

• 5) 橋本 清, 志田原睦雄:子宮癌登録委員会臨時報告-現在の治療方法(1969)について. 日本産科婦人科学会雑誌1970;22:1093

• 6) 平林光司, 久保久光, ほか:わが国における子宮頸癌治療成績の国際的評価と治療集中化の必要性について. 癌の臨床1974;20:645-654

• 7) 大阪府立成人病センター調査部 国立がんセンター研究所:第II編 第1部 患者調査(7)3年相対生存率, 第III編 関連資料・データ集2. 過去4回の悪性新生物実態調査内容. 数字でみるがん'90-第5次悪性新生物実態調査報告(末舛恵一, 厚生省保険医療局疾病対策課, 監). 1990;pp33-36, p139, 総合医学社, 東京

• 8) Bailer III JC, Smith EM:Progress against cancer? N Engl J Med 1986;314:1226-1232

• 9) 日本産科婦人科学会 子宮癌登録委員会:厚生省がん研究助成金班研究報告. 子宮頸癌全国調査成績, 第3報(1977), 第4報(1978), 第5報(1988), 第6報(1995)

• 10) 垣添忠生, 中村吉夫, ほか:2. 国立がんセンター中央病院における多重がんのO/E比(昭和37年-平成元年), 11. 多重がんの臓器組合わせ(昭和37年-平成元年). がんの統計'97(「がんの統計」編集委員会, 編). 1997;pp58-59, がん研究振興財団, 東京

• 11) 安部泰史, 小野与満夫, ほか:年齢調整死亡率(年齢訂正死亡率)の改定について. 厚生の指標1991;38:12-16

• 12) 有本弘子, 北川千恵子, 荒井博:Cohort生存率について. 厚生の指標1985;32:2530

• 13) 大阪府環境保健部, 大阪府医師会, 大阪府立成人病センター:2. 観察対象および方法3)登録制度. 大阪府におけるがん患者の生存率1975-89年. 1998;p6, 篠原出版, 東京

• 14) Cutler SJ, Ederer F:Maximum utilization of the life table method immalyzing survival. J Chron Dis 1958;8:699-712

• 15) Pettersson F(ed):Annual Report on the Results of Treatment in Gynecological Cancer. vol 20. 1993;pp46-47, International Federation of Gynecology and Obstetrics. Stockholm

• 16) 中桐善康, 奥田博之, ほか:子宮頸癌の長期予後とその管理. 産科と婦人科1989;56:1901-1905

• 17) UICC TNM Committee:Gynecological tumours. Cervix Uteri (ICD O C53) UICC TNM Classification or Malignant Tumours (Sobin LH, Eittekin CH, eds), 5th ed. 1997;pp142-146, John Wiley & Sons, New York, Chichester, Weinheim, Brisbane, Singerpore, Toronto

• 18) Scully RE, Bonfiglio TA, et al:Histological Typing of Female Genital Tract Tumours, 2nd ed. 1994;pp3947, Springer-Verlag. Berlin, Heiderberg. New York, London, Paris, Tokyo, Hong-Kong, Barcelona, Budapest

• 19) Perez CA, Kurman RJ, et al:General Management/Results of Therapy. Principles and Practice of Gynecologic Oncology (Hos kins WJ, Peraz CA, Young RC, eds). 1992;pp610-620, 626-648. JB Lippincott, Philadelphia

• 20) Liu W, Meigs JV:Radical hysterectomy and pelvic lymphadenectomy:A review of 473 cases including 244 for primary invasive carcinoma of the cervix. Am J Obstet Gynecol 1955;69:1-32

• 21) Christensen A, Lange P, Neilsen E:Surgery and radiotherapy for invasive cancer of the cervix:Surgical treatment. Acta Obstet Gynecol Scand 1964;43:59-87

• 22) Brunschwig A, Barber HRK:Surgical treatment of carcinoma of the cervix. Obstet Gynecol 19661;27:21-29

• 23) Symmonds RE:Morbidity and complications of radical hysterectomy with pelvic lymph node dissection. Am J Obstet Gynecol 1966;94:663-678

• 24) Masterson JG:The role of surgery in the treatment of easily carcinoma of the cervix. Clin Obstet Gynecol 1967;10:922-939

• 25) Blaikley JB, Lederman M, Pollard W:Five-year and 1-year results of treatment. J Obstet Gynaecol Br Commonw 1969;76:729-740

• 26) Newtori M:Radical hysterectomy or radiotherapy for stage I cervical cancer. Am J Obstet Gynecol 1975;123:535-542

• 27) Hoskins WJ, Ford JH Jr, et al:Radical hysterectomy and pelvic lymphadenectomy for the management of early invasive cancer of the cervix. Gynecol Oncol 1976;4:278-290

• 28) Underwood PB Jr, Wilson WC, et al:Radical hysterectomy:A critical review of 22 years' experience. Am J Obstet Gynecol 1979;134:889-898

• 29) Van Nagell JR Jr, Rayburn W, et al:Therapeutic implications of patterns of recurrence in cancer of the uterine cervix. Cancer 1979;44:2354-2361

• 30) Benedet JL, Turko M, et al:Radical hysterectomy in the treatment of cervical cancer. Am J Obstet Gynecol 1980;137:254:262

• 31) Artman LE, Hoskins WJ, et al:Radical hysterectomy and pelvic lymphadenectomy for stage IB carcinoma of the cervix:21 years experience. Gynecol Oncol 1987;28:8-13

• 32) Piver MS, Marchetti DL, et al:Radical hysterectomy and pelvic lymphadenectomy versus radiation therapy for small(≧3cm)stage IB cervical carcinoma. Am J Clin Oncol 1988;11:21-24

• 33) Lee Y-N, Wang KL, et al:Radical hystcrectomy with pelvic lymph node dissection for the treatment of cervical cancer:A clinical review of 954 cases. Gynecol Oncol 1989;32:135-142

• 34) Wall JA, Collins VP, et al:Carcinoma of the cervix:Review of clinical experience during a 20-year period. Am J Obstet Gynecol 1966;96:57-63

• 35) Muirhead W, Green LS:Carcinoma of the cervix:Five-year results and sequelae of treatment. Am J Obstet Gynecol 1968;101:744-749

• 36) Kline JC, Schultz AE, et al:High dose radiotherapy for carcinoma of the cervix. Am J Obstet Gynecol 1969;104:479-484

• 37) Dickson RJ:Late results of radium treatment of carcinoma of the cervix. Clin Radiol 1972;23:528-535

• 38) Kottmeier HL(ed):Annual Report on the Results of Treatment in Carcinoma of the Uterus, Vagina and Ovary, vol 15. 1973, International Federation of Gynecology and Obstetrics, Stockholm

• 39) Fletcher GH:Textbook of Radiotherapy, 3rd ed. 1980;pp720-773, 812-828, Lea & Febiger, Philadelphia

• 40) 山辺 徹:子宮頸部腺癌の病態と治療教育シンポジウム4. 第31回日本癌治療学会総会-特別演題抄録集. 1993;pp65-68, 日本癌治療学会, 大阪

• 41) Waldenstrom A-C, Horvath G:Survival of patients with adenocarcinoma of the uterine cervix in western Sweden. Int J Gynecol Cancer 1999;9:18-23
  pubmed

• 42) 野田起一郎:昭和62, 63年度厚生省がん研究助成金62-25「子宮頸部腺癌の治療法確立に関する研究」報告集. 1989;pp231-236

• 43) Shingleton HM, Bell MC et al:Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer 19951 (suppl) 75:1948-1955

• 44) Fyles A, Kirkbride P:Tumor-related factors, anatomic extent of disease, 20 cervix uteri carcinoma. Prognostic Factors in Cancer. 1995;pp186-188. Springer, Berlin

• 45) Vermoken JB:combined modality treatment in cervical cancer:Neoadjuvant chemotherapy and surgery. Hematology/oncology clinics of North America. Current Therapeutic Issues in Gynecologic Cancer 1999;13:290-298

• 46) 塚本直樹:子宮頸癌に対するNeoadjuvant Chemotherapy ディスカッサントのコメント. 産科と婦人科1995;62:1257-1260

• 47) 河西十九三, 荒居竜雄, 高見澤裕吉:再発子宮頸癌の治療-放射線治療を中心に. 産科と婦人科1986;53:1371-1377

• 48) 近江和夫, 笠松達弘, ほか:頸癌・体癌の転移をめぐる諸問題. 産科と婦人科1989;56:1847-1853

• 49) 園田隆彦:頸癌の長期予後とその管理-最近の日本における子宮頸癌の情況. 産科と婦人科 1989;56:1979-1982

• 50) 荷見勝彦, 平井康夫, ほか:子宮頸癌の長期予後とその管理. 産科と婦人科1989;56:1885-1890

P.395 掲載の参考文献

• 1) 横 山 隆, 藤岡 徹ほか:子宮頸癌の腫瘍径と治療成績-組織型での比較検討. 産科と婦人科1997;64:1004 1008

• 2) 塚本直樹:子宮頸癌-手術療法. 産科と婦人科1995;162:167-172

• 3) Kamura T, Tsukamoto N, Tsuruchi N:Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy, Cancer 1991;69:181-186

• 4) DiSaia PJ, Creasman WT:Clinical Gynecologic Oncology. 1997;pp51-106, Mosby-Year Book, St Louis

• 5) 白水健士, 石本一也, ほか:子宮頸癌の術後放射線療法の適応と予後-予後からみた適応の再検討. 産科と婦人科1993;60:1265-1270

• 6) 婦人科腫瘍委員会:第35回治療年報. 日本産科婦人科学会雑誌1998;50:278-308

• 7) 白水健士, 松澤真澄, ほか:子宮頸癌骨盤リンパ節転移陽性例の臨床病理学的検討. 産婦人科の実際1987;36:1515-1522

• 8) 荷見勝彦:婦人科癌再発を疑うポイント. 日本産科婦人科学会雑誌1997;49:N15-N18

• 9) 吉野内光夫, 中村圭一郎, ほか:子宮頸癌術後再発の予知. 産婦人科治療1998;77:436-440

• 10) Shiromizu K, Kasamatsu T, et al:Clinicopathological study of recurrent uterine cervical squamous cell carcinoma. J Obstet Gynecol Res 1999;25:395-399

• 11) 富樫かおり:女性生殖器のMRI診断. 日本医学放射線学会雑誌1995;55:281-288. (suppl) 10-14

• 12) 伏木 弘, 泉 陸一・:了宮癌のリンパ節転移と画像診断. 産婦人科治療1996;72:788-795

• 13) 中原信哉, 上谷雅孝, 林邦昭:仙骨のinsufficiency fractureのMR imagingその特徴と骨転移の鑑別について. 日本医学放射線学会雑誌1995;55:281-288

• 14) 加藤 紘, 尾懸秀信:子宮頸癌と腫瘍マーカー. 産婦人科治療1998;77:410-413

• 15) 安田 允, 青木雅弘, ほか:子宮頸癌に対するNeoadjuvant化学療法-動注化学療法を中心に. 産科と婦人科1995;62:1229-1234

• 16) 小西郁生, 南部香成子, ほか:子宮頸癌におけるNeoadjuvant動注化学療法の直接効果と患者の余語. 産科と婦人科1995;62:1237-1241

• 17) 鈴木康伸, 武市 信, ほか:進行子宮頸癌に対するNeoadjuvant動注COMPA療法と, 高用量CEP療法の有用性に関する検討. 産科と婦人科1995;62:1243-1248

• 18) 早瀬良二, 山本昌彦, ほか:進行子宮頸癌に対するNeoadjuvant Chemotherapy. 産科と婦人科 1995;62:1251-1254

• 19) 塚本直樹:子宮頸癌に対するNeoadjuvant Chemotherapy-ディスカッサントのコメント. 産科と婦人科1995;62:1257-1260

• 20) 植木 實, 岡村信介, ほか;進行子宮頸癌に対する動注化学・塞栓療法の検討と考察-ディスカッサントとしての発言を含めて. 産科と婦人科1995;62:1261-1265

• 21) Shiromizu K, Ogawa M, et al:Reconstruction of sigmoid vagina and conduit in total pelvic exenteration. Jpn J Clin Oncol 1989;19:170-172

• 22) Shiromizu K Kasamatsu T, et al:Clinicopathological study of postoperative pulmonary metastasis of uterine cervical carcinoma. J Obstet Gynaecol Res 1999;25:245-249

• 23) 秋根康之, 園田隆彦:子宮頸癌-放射線療法. 産科と婦人科1995;62:175-179

• 24) 小塚隆弘, 井上俊彦:小線源放射線治療. 1993, 中山書店, 東京

• 25) Mal fetano J, Keys H, et al:Weekly cisplatin and radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma. Cancer 1993;71:3703-3706

• 26) 杉山 徹:新しい抗癌剤と婦人科腫瘍. 産科と婦人科1997;64:787-793

• 27) 平林光司:子宮項癌-化学療法. 産科と婦人科1995;62:180-183

• 28) 小西郁生:Neoadjuvant chemotherapy-子宮頸癌. 産科と婦人科1998;65:31-36

• 29) 高橋秀子, 木花敏雅, ほか:Cisplatin, Carboplatin併用化学療法が著効した子宮頸部扁平上皮癌肺転移の2症例. 産科と婦人科1996;63:719-722

• 30) 工藤隆一, 早川 修:子宮頸癌-予後からみた治療法の選択. 産科と婦人科1995;62:158-164

• 31) 柏木哲夫:ホスピスケアと緩和医療学(背景と歴史). 緩和医療学(柏木哲夫, 石谷邦彦, 編). 1997, 三輪書店, 東京

• 32) 武田文和(訳):がんの痛みからの解放-WHO方式がん疼痛治療法. 1996;pp3-41, 金原出版, 東京

• 33) 田垣内祐吾, 西野 卓:がん患者の疼痛対策と実際. 産科と婦人科1997;64:795-802

• 34) Shiromizu K, Kasamatsu T, et al:Chnicopathological study of uterine cervical non-squamous cell carcinoma. 1998, 第36回日本癌治療学会発表, 福岡

P.409 掲載の参考文献

• 1) 天野純治, 松林冨士男:後天性難治性直腸腟瘻. 外科治療1981;45:417-427

• 2) 伊藤邦彦, 玉舎輝彦:子宮頸癌治療の広汎子宮全摘出術施行後に起こる術後感染症防止に関する研究. 岐阜大学医学部紀要1991;39:498-511

• 3) 木村修治, 河野通雄(編):放射線治療学. 1996, 金芳堂, 京都

• 4) 小林 隆:子宮頸癌手術. 1961, 南山堂, 東京

• 5) 九嶋 理, 高橋 道, ほか:後腹膜リンパ無縫合の腹腔内癒着・下肢リンパ浮腫におよぼす影響についての実験的ならびに臨床的研究. 秋田医学1996;23:97-103

• 6) 森本一男, 鵜飼和浩, ほか:子宮頸癌に対する放射線治療後の骨盤周囲の骨壊死. 日本癌治療学会誌1992;27:819-826

• 7) 村上充剛, 古谷健一, ほか:婦人科悪性腫瘍の術後リンパ嚢胞発生に対する骨盤腹膜無縫合術式の検討. 日本産科婦人科学会雑誌1998;50:363-365

• 8) 中塚幹也, 児玉順一, ほか:子宮頸癌放射線治療と二次発癌. 臨床婦人科産科1990;44:181-185

• 9) 西田正人, 稲葉淳一, ほか:頸癌術後に発生した巨大リンパ嚢胞の腹腔内ドレナージによる治療. 産科と婦人科1990;57:2275-2279

• 10) 西村隆一郎, 長谷川和男:尿路・直腸損傷の予防と対策. 図説産婦人科VIEW30, 子宮頸癌の根治手術(矢嶋 聰, 桑原慶紀, 編). 1998;pp132-147, メジカルビュー社, 東京

• 11) 野崎功雄, 横山伸二, 高嶋成光:子宮頸癌放射線治療後の腸管障害に対する外科治療. 日本腹部救急医学会雑誌1997;17:477-482

• 12) 岡部親宣, 斎藤英樹, ほか:子宮頸癌術後におけるリンパ嚢胞およびリンパ膿瘍症例の検討. 日本産科婦人科学会東京地方部会会誌1992;41:298-302

• 13) 大津文子, 長谷川和男, ほか:子宮癌治療後症例における重複癌および2次癌の検討. 産婦人科の進歩1994;46:138-145

• 14) 佐藤孝道:産婦人科手術指針. 1997, 中外医学社, 東京

• 15) 十亀真志, 牧野田知, ほか:腹部救急診療におけるドレナージトラブル. 骨盤死腔炎予防用経腟ドレナージの問題点. 腹部救急診療の進歩1989;9:561-565

• 16) 塚本直樹:子宮頸癌根治手術におけるリンパ節郭清時の注意. 産婦人科の実際1995;44:393-398

• 17) 矢吹朗彦, 朝本明弘, ほか:広汎性子宮全摘術において側方靱帯を意識した基靱帯切除法. 産科と婦人科1989;156:1929-1934

• 18) 安野博彦, 中村一郎, ほか:放射線性萎縮膀胱に併発した腹腔内膀胱自然破裂の1例. 西日本泌尿器科1985;48:1679-1683

• 19) Blandy JP:Rob & Smith's Operative Surgery, 5th ed. 1993. Butterworths-Heinenmann, Oxford

• 20) Kabalin JN:Cambell's Urology, 6th ed. 1992. WB Saunders, Philadelphia

• 21) Marshal FF;Textbook of Operative Urology. 1991, WB Saunders. Philadelphia

• 22) Rock JA, Thompson JD:The Linde's Operative Gynecology, 8th ed. 1996, JB Lippincott, Philadelphia

P.420 掲載の参考文献

• 1) Boyes DA, Worth AJ, Fidler HK:The results of treatment of 4389 cases of pre-clinical cervical squamous cell carcinoma. J Obstet Gynecol Br Common 1970;77:769-780

• 2) Creasman WT, Rutledge F:Carcinoma in situ of the cervix:An analysis of 861 patients. Obstet Gynecol 1972;39:373-380

• 3) Kolstad P, Klem V:Long-term follow up of 1121 cases or carcinoma in situ. Obstet Gynecol 1976;48:125-129

• 4) Morris M, Mitchell MF, et a:Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix. Gynecol Oncol 1993;51:193-196

• 5) 脇田邦夫, 蔵本博行, 西島正博:若年者における機能温存・機能代償:子宮頸癌-妊孕能温存 (とくにレーザー療法による). 産科と婦人科1998;65:703-710

• 6) 三国雅人, 晴山仁志, ほか:妊娠合併子宮頸癌の管理方法-当科での経験症例を中心に. 産婦人科手術1992;3:112-119

• 7) 室谷哲弥, 末広 寛, ほか:早期子宮頸癌の光線力学的治療. 癌と化学療法1996;23:47-56

• 8) Toki N, Tsukamoto N, et al:Microscopic ovarian metastasis of uterine cervical cancer. Gynecol Oncol 1991;41:46-51

• 9) Sutton GP, Bundy BN, et al:Ovarian metastases in Stage IB carcinoma of the cervix:A Gynecologic Oncology Group Study. Am J Obstet Gynecol 1992;166:50-53

• 10) 泉 陸一, 新居 隆, ほか:Quality of Lifeからみた癌手術療法の進歩-子宮頸癌. 癌と化学療法1990;17:749-755

• 11) Windbichler GH, Muller Holzner E, et al:Ovarian preservation in the treatment of cervical carcinoma. Am J Obstet Gynecol 1999;180:963-969

• 12) Chambers SK, Chambers JT, et al:Sequelae of lateral ovarian transposition in irradiated cervical cancer patients. Int J Radiat Oncol Biol Phys 1991;20:1305-1308

• 13) 大野精七:卵巣ノ乳腺下移植ニ就テ. 日本婦人科学会雑誌1929;25:1100-1112

• 14) 八木日出雄:卵巣移植術-特に子宮頸癌手術と卵巣自家移植の経験. 手術1957;5:274-277

• 15) Krebs C, Blixenkrone-Moller N:Ovarian function after combined surgical and radiologic treatment of early cervical cancer. Acta Radiot 1958;49:128-136

• 16) Kovacev M:Exteriorization of ovaries under the skin of young women operated upon for cancer of the cervix. Am J Obstet Gynecol 1968;101:756-769

• 17) 椎名美博:動静脈温存法による卵巣移植術の検討. 北海道医学雑誌1983;58:575-586

• 18) DiSaia PJ:Surgical aspects of cervical carcinoma. Cancer 1981;48:548-549

• 19) Belinson JL, Doherty M, McDay JB:A new technique for ovarian transposition. Surg Gynecol Obstet 1984;159:157-160

• 20) Morice P, Castaigne D, et al:Laparoscopic ovarian transposition for pelvic malignancies:Indications and functional outcomes. Fertil Steril 1998;70:956-960

• 21) Treissman MJ, Miller D, McComb PF:Laparoscopic lateral ovarian transposition. Fertil Steril 1996;65:1229-1231

• 22) Ellsworth LR, Allen HH, Nisker JA:Ovarian function after radical hysterectomy for stage 1B carcinoma of cervix. Am J Obstet Gynecol 19831;45:185-188

• 23) Owens S, Roberts WS, et al:Ovarian management at the time of radical hysterectomy for cancer of the cervix. Gynecol Oncol 1989;35:349-351

• 24) Anderson B, Lapolla J, et al:Ovarian transposition in cervical cancer. Gynecol Oncol 1993;49:206-214

• 25) Ichinoe K:Functional Preservasion of Gynecologic Reproductive Organs by Operative and Nonoperative Procedures. Hokkaido University Medical Library Series, vol 20. 1986, Kokoku Printing, Sapporo

• 26) 三谷 靖, 山辺 徹:子宮頸癌術後合併症. 現代産科婦人科学大系8E, 子宮頸癌. 1970;pp105-126, 中山書店, 東京

• 27) 加藤喜市, 海宝てる代, 武田祥子:子宮全摘後の性機能に関する各種術式と卵巣摘出の影響. 産婦人科の実際1982;31:109-115

• 28) Saito M, Kumasaka T, et al:Vaginal repair in the radical operation for cervical carcinoma. Acta Obstet Gynecol Scand 1976;55:151-154

• 29) 大久保仁:広汎性子宮全摘術後の腟再建に関する臨床的ならびに組織学的検討. 北海道医学雑誌 1987;62:311-321

P.428 掲載の参考文献

• 1) 河野一郎:告知をめぐる問題点(悪性腫瘍). 臨床婦人科産科1994;48:542-544

• 2) 淀川キリスト教病院ホスピス(編):ターミナルケアマニュアル, 第3版. 1997, 最新医学社, 大阪

• 3) 世界保健機関(編):がんの痛みからの解放とパリアティブ・ケア-がん患者の生命のよき支援のために. 1993, 金原出版, 東京

• 4) Bonica JJ:Cancer pain. The Management of Pain (Bonica JJ, ed), 2nd ed. 1990;pp400-460, Lea & Febiger, Philadelphia

• 5) 世界保健機関(編):がんの痛みからの解放-WHO方式がん疼痛治療法. 1987, 金原出版, 東京

• 6) Massie MJ, Holland JC:The cancer patients with pain:Psychiatric complications and their management. J Pain Symptom Manage 1992;7:99-109

• 7) Walsh TD:Prevention of opioids side effects. J Pain Symptom Manage 1990;5:362-367

その他の子宮頸部悪性腫瘍と転移癌

P.438 掲載の参考文献

• 1) Scully RE, Bonfiglio TA, et al:Histological typing of female genital tract tumours. World Health Organization. International Histological Classification of Tumours, 2nd ed. 1994;pp14-18, Springer Verlag, Berlin

• 2) Abell MR, Ramirez JA:Sarcomas and carcinosarcomas of the uterine cervix. Cancer 1973;31:1176-1192

• 3) Rotmensch J, Rosenshein NB, Woodruff JD:Cervical sarcoma:A review. Obstet Gynecol Surv 1983;38:456-460

• 4) Bell SW, Kempson RL, Hendrickson MR:Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 1994;18:535-558

• 5) Abdul-Karim FW, Bazi TM, et al:Sarcoma of the uterine cervix:Clinicopathologic findings in three cases. Gynecol Oncol 1987;26:103-111

• 6) Clement PB:Miscellaneous primary tumors and metastatic tumors of the uterine cervix. Semin Diagn Pathol 1990;7:228-248

• 7) Daya DA, Scully RE:Sarcoma botryoides of the uterine cervix in young women:A clinicopathological study of 13 cases. Gynecol Oncol 1988;29:290-304

• 8) Brand E, Berek JS, et al:Rhabdomyosarcoma of the uterine cervix. Sarcoma botryoides. Cancer 1987;60:1552-1560

• 9) Gordon AN, Montag TW:Sarcoma botryoides of the cervix:Excision followed by adjuvant chemotherapy for preservation of reproductive function. Gynecol Oncol 1990;36:119-124

• 10) Ordonenz NG:Alveolar soft part sacroma:A review and update. Adv Anat Pathol 1999;6:125-139

• 11) Nakano H:Alveolar soft part sarcoma:Histogenesis. Anticancer Res 1998;18:4207-4211

• 12) Abeler V, Nesland JM:Alveolar soft part sarcoma in the uterine cervix. Arch Pathol Lab Med 1989;113:1179-1183

• 13) Sahin AA, Silva EG, Ordonez NG:Alveolar soft part sarcoma of the uterine cervix. Mod Pathol 1989;2:676-680

• 14) Zaloudek CJ, Norris HJ:Adenofibroma and adenosarcoma of the uterus:A clinicopathologic study of 35 cases. Cancer 1981;48:354-366

• 15) Silverberg SG, Major FJ, et al:Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus:A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 1990;9:1-19

• 16) Costa MJ, Khan R, Judd R:Carcinosarcoma (malignant mixed mullerian [mesodermal] tumor) of the uterus and ovary:Correlation of clinical, pathologic, and inimunohistochemical features in 29 cases. Arch Pathol Lab Med 1991;115:583-590

• 17) Sreenan JJ, Hart WR:Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors:Further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis.
  pubmed

• 18) Hall-Craggs M, Toker C, Nedwich A:Carcinosarcoma of the uterine cervix:A light and electronicroscopic study. Cancer 1981;48:161-169

• 19) Gersell DJ, Duncan DA, Fulling KH:Malignant mixed mullerian tumor of the uterus with neuroectodermal differentiation. Int J Gynecol Pathol 1989;8:169-178

• 20) Bell DA, Shimm DS, Gang DL:Wilms' tumor of the endocervix. Arch Pathol Lab Med 1985;109:371-373

• 21) Mordel N, Mor-Yosef S, et al:Malignant melanoma of the uterine cervix:Case report and review of the literature. Gynecol Oncol 1989;32:375-380

• 22) Chorlton I, Karnei RF Jr, et al:Primary malignant reticuloendothelial disease involving the vagina, cervix, and corpus uteri. Obstet Gynecol 1974;44:735-748

• 23) Harris NL, Scully RE:Malignant lymphoma and granulocytic sarcoma of the uterus and vagina:A clinicopathologic analysis of 27 cases, Cancer 1984;53:2530-2545

• 24) Komaki R, Cox JD, et al:Malignant lymphoma of the uterine cervix. Cancer 1984;54:1699-1704

• 25) Mann R, Roberts WS, et al:Primary lymphoma of the uterine cervix. Gynecol Oncol 1987;26:127-134

• 26) Anderson GG:Hodgkin's disease of the uterine cervix:Report of a case. Obstet Gynecol 1967;29:170-172

• 27) Young RH, Harris NL, Scully RE:Lymphoma-like lesions of the lower female genital tract:A report of 16 cases. Int J Gynecol Pathol 1985;4:289-299

P.445 掲載の参考文献

• 1) Kashimura M, Kashimura Y, et al:Adenocarcinoma of the uterine cervix metastatic from primary stomach cancer:Cytologic findings in six cases. Acta Cytol 1983;27:54-58

• 2) Miller BE, Flax SD, et al:The presentation of adenocarcinoma of the uterine cervix. Cancer 1993;72:1281-1285

• 3) Wallach JB, Edberg S:Carcinoma metastatic to the uterine cervix. Am J Obstet Gynecol 1959;77:990-995

• 4) Imachi M, Tsukamoto N, et al:Metastatic adenocarcinoma to the uterine cervix from gastric cancer. Cancer 1993;71:3472-3477

• 5) Lemoine NR, Hall PA:Epithelial tumors metastatic to the uterine cervix:A study of 33 cases and review of the literature. Cancer 1986;57:2002-2005

• 6) Ng ABP, Teeple D, et al:The cellular manifestations of extrauterine cancer. Acta Cytol 1974;18:108-117

• 7) Matsuura Y, Saito R, et al:Cytologic analysis of primary stomach adenocarcinoma metastatic to the uterine cervix. Acta Cytol 1997;41:291-294